Collective Molecular Activities of the Plant: Phytolacca Americana
Example Image
PLANiTS DNA barcode
Taxonomic Information
Used in Medicines
Country/Region:
South Africa; India; United States; Vietnam; China; LaosTraditional Medicine System:
TCM; HomeopathyMedicinal Functions:
Alterative; Anodyne; Antiinflammatory; Antirheumatic; Antiviral; Cancer; Cathartic; Expectorant; Homeopathy; Hypnotic; Narcotic; Purgative
Geographical Distribution
Turkey; Italy; France; Laos; Bolivia; Algeria; Cape Verde; China; Germany; Spain; Ukraine; Liberia; Netherlands; Mauritius; Morocco; Vietnam; Switzerland; Bulgaria; United States; Romania; Albania; Portugal; Mexico; Tunisia; South Africa; India; Lesotho; Austria; Greece; Hungary
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Compounds Summary
Overview of Ingredients
95 All known Ingredients in Total
Unique ingredients have been isolated from this plant.Plant-Ingredients Associations were manually curated from publications or collected from other databases.
48 Ingredients with Acceptable Bioavailablity
Unique ingredients exhibit acceptable human oral bioavailablity, according to the criteria of SwissADME [PMID: 28256516] and HobPre [PMID: 34991690]. The criteria details:SwissADME: six descriptors are used by SwissADME to evaluate the oral bioavailability of a natural product:
☑ LIPO(Lipophility): -0.7 < XLOGP3 < +5.0
☑ SIZE: 150g/mol < MW < 500g/mol
☑ POLAR(Polarity): 20Ų < TPSA < 130Ų
☑ INSOLU(Insolubility): -6 < Log S (ESOL) < 0
☑ INSATU(Insaturation): 0.25 < Fraction Csp3 < 1
☑ FLEX(Flexibility): 0 < Num. rotatable bonds < 9
If 6 descriptors of a natural plant satisfy the above rules, it will be labeled high HOB.
HobPre: A natural plant ingredient with HobPre score >0.5 is labeled high human oral availability (HOB)
44 Ingredients with experimental-derived Activity
Unique ingredients have activity data available.Ingredient Structrual Cards
Ingredient ID: NPC96675
Ingredient ID: NPC94167
Ingredient ID: NPC91350
Ingredient ID: NPC79253
Ingredient ID: NPC74929
Ingredient ID: NPC69445
Ingredient ID: NPC68255
Ingredient ID: NPC66347
Ingredient ID: NPC59650
Ingredient ID: NPC58928
Ingredient ID: NPC56189
Ingredient ID: NPC55412
Ingredient ID: NPC50052
Ingredient ID: NPC490424
Ingredient ID: NPC489907
Ingredient ID: NPC48124
Ingredient ID: NPC479113
Ingredient ID: NPC479112
Ingredient ID: NPC479111
Ingredient ID: NPC479110
Ingredient ID: NPC479109
Ingredient ID: NPC479108
Ingredient ID: NPC473405
Ingredient ID: NPC473401
Ingredient ID: NPC473383
Ingredient ID: NPC473373
Ingredient ID: NPC473343
Ingredient ID: NPC471550
Ingredient ID: NPC471548
Ingredient ID: NPC471547
Ingredient ID: NPC44723
Ingredient ID: NPC34864
Ingredient ID: NPC328447
Ingredient ID: NPC327670
Ingredient ID: NPC327496
Ingredient ID: NPC325473
Ingredient ID: NPC325422
Ingredient ID: NPC323242
Ingredient ID: NPC320830
Ingredient ID: NPC318696
Ingredient ID: NPC309714
Ingredient ID: NPC307796
Ingredient ID: NPC307504
Ingredient ID: NPC301138
Ingredient ID: NPC293714
Ingredient ID: NPC289315
Ingredient ID: NPC27797
Ingredient ID: NPC269919
Ingredient ID: NPC268761
Ingredient ID: NPC256186
Ingredient ID: NPC253060
Ingredient ID: NPC249352
Ingredient ID: NPC248970
Ingredient ID: NPC242580
Ingredient ID: NPC234689
Ingredient ID: NPC231018
Ingredient ID: NPC219138
Ingredient ID: NPC214729
Ingredient ID: NPC214148
Ingredient ID: NPC201844
Ingredient ID: NPC201089
Ingredient ID: NPC197381
Ingredient ID: NPC195848
Ingredient ID: NPC192040
Ingredient ID: NPC187770
Ingredient ID: NPC185498
Ingredient ID: NPC184560
Ingredient ID: NPC17810
Ingredient ID: NPC174342
Ingredient ID: NPC172333
Ingredient ID: NPC171495
Ingredient ID: NPC1682
Ingredient ID: NPC167400
Ingredient ID: NPC150950
Ingredient ID: NPC147983
Ingredient ID: NPC145620
Ingredient ID: NPC142415
Ingredient ID: NPC141074
Ingredient ID: NPC139894
Ingredient ID: NPC137382
Ingredient ID: NPC136014
Ingredient ID: NPC135585
Ingredient ID: NPC132380
Ingredient ID: NPC131733
Ingredient ID: NPC130683
Ingredient ID: NPC127853
Ingredient ID: NPC11869
Ingredient ID: NPC112866
Ingredient ID: NPC109851
Ingredient ID: NPC109588
Ingredient ID: NPC106389
Ingredient ID: NPC105965
Ingredient ID: NPC10305
Ingredient ID: NPC100207
Ingredient ID: NPC100128
Classification of Human Proteins Collectively Targeted by the Plant
*The classification criteria of Drug Transporter (DTP), CYP450 are referred to DrugMap. Other molecular targets in CMAUP are classified as therapeutic targets.
.
Detailed Information of Target Proteins
| Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|---|
| Therapeutic Target | Enzyme | CES1 | Acyl coenzyme A:cholesterol acyltransferase | P23141 | CHEMBL2265 |
| Therapeutic Target | Enzyme | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
| Therapeutic Target | Histone acetyltransferase | NCOA3 | Nuclear receptor coactivator 3 | Q9Y6Q9 | CHEMBL1615382 |
| Therapeutic Target | Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
| Therapeutic Target | Isomerase | TOP2B | DNA topoisomerase II beta | Q02880 | CHEMBL3396 |
| Therapeutic Target | Lyase | GLO1 | Glyoxalase I | Q04760 | CHEMBL2424 |
| Therapeutic Target | Membrane receptor | APP | Beta amyloid A4 protein | P05067 | CHEMBL2487 |
| Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
| Therapeutic Target | Nuclear hormone receptor subfamily 1 | THRB | Thyroid hormone receptor beta-1 | P10828 | CHEMBL1947 |
| Therapeutic Target | Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
| Therapeutic Target | Oxidoreductase | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
| Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
| Therapeutic Target | Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
| Therapeutic Target | Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
| Drug Transporter | SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
| Therapeutic Target | Small molecule receptor (family A GPCR) | HCAR2 | Hydroxycarboxylic acid receptor 2 | Q8TDS4 | CHEMBL3785 |
| Therapeutic Target | Small molecule receptor (family A GPCR) | ADRA2B | Alpha-2b adrenergic receptor | P18089 | CHEMBL1942 |
| Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
| Therapeutic Target | Surface antigen | F3 | Coagulation factor III | P13726 | CHEMBL4081 |
| Therapeutic Target | Transferase | GSTP1 | Glutathione S-transferase Pi | P09211 | CHEMBL3902 |
| Therapeutic Target | Unclassified protein | SNCA | Alpha-synuclein | P37840 | CHEMBL6152 |
Clinical Trials Summary
Overview
Clinical trials associated with plant from natural product (NP) & plant level:
| Clinical trials type | Number of clinical trials | |
|---|---|---|
 NP level | 1553 | |
 Plant level | 1 | |
Clinical trial details
| NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
|---|---|---|---|---|
| NCT00002905 | Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02987998 | Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00774046 | High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT01057615 | Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma | asthma | Ascorbate (NPC187770) | NP level |
| NCT01492556 | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT01612221 | Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo | melanoma | Acetylcysteine (NPC248970) | NP level |
| NCT02990364 | Combination Analgesia for Neonatal Circumcision | pain | Sucrose (NPC130683) | NP level |
| NCT02896582 | Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01059071 | Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01390584 | Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03028467 | Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00591630 | Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02402920 | Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04301336 | Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia | sickle cell anemia | Folic Acid (NPC147983) | NP level |
| NCT03522922 | Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring | acne | Ascorbate (NPC187770) | NP level |
| NCT00009815 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00664287 | Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00006258 | Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00003190 | Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia | acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia with maturation;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia | Etoposide (NPC185498) | NP level |
| NCT01371981 | Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | myeloid sarcoma | Etoposide (NPC185498) | NP level |
| NCT00998946 | Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | lymphoma | Folic Acid (NPC147983) | NP level |
| NCT00446147 | Study of Pyridoxine for Hand-Foot Syndrome | Hand-foot syndrome | Pyridoxine (NPC269919) | NP level |
| NCT01589159 | A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00920413 | Oral Vitamin C for Correction of Anemia in Patients Receiving Peritoneal Dialysis | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
| NCT03797443 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
| NCT04712903 | Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00082251 | Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT04871607 | Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02306291 | Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01083329 | Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects | obesity | Niacin (NPC167400) | NP level |
| NCT00070174 | Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy | leukemia | Etoposide (NPC185498) | NP level |
| NCT00070200 | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00027898 | Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT01407432 | Impact of Folates in the Care of the Male Infertility | male infertility | Folic Acid (NPC147983) | NP level |
| NCT01014546 | Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis | essential thrombocythemia;polycythemia vera;primary myelofibrosis | Ascorbate (NPC187770) | NP level |
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00533312 | MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT02219737 | Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00626392 | Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01664260 | Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder | post-traumatic stress disorder | Acetylcysteine (NPC248970) | NP level |
| NCT00953212 | Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery | atrial fibrillation;atrial flutter | Ascorbate (NPC187770) | NP level |
| NCT00233987 | S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004904 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | graft versus host disease;chronic myeloproliferative disorder;leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00776698 | A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01014767 | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | brain cancer;choroid plexus neoplasm | Etoposide (NPC185498) | NP level |
| NCT00032149 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002516 | Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00537511 | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03019640 | Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004169 | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00829205 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00633581 | Efficacy of Vitamin C Injection on Fatigue in Workers After Work | Fatigue | Ascorbate (NPC187770) | NP level |
| NCT00000161 | Randomized Trials of Vitamin Supplements and Eye Disease | cataract | Beta Carotene (NPC17810);Ascorbate (NPC187770) | NP level |
| NCT01013779 | Merkel Positron Emission Tomography (PET) Protocol | Merkel cell skin cancer | Etoposide (NPC185498) | NP level |
| NCT00145002 | A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) | adult T-cell leukemia/lymphoma | Etoposide (NPC185498) | NP level |
| NCT00769132 | A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT00002757 | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT04898023 | Zinc and Green Tea Extract for Community Respiratory Viral Infections | viral disease | Ascorbate (NPC187770) | NP level |
| NCT02043587 | Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT03519971 | Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00077285 | Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00005978 | N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00062439 | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00111891 | An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00402883 | Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer | lung cancer | Folic Acid (NPC147983) | NP level |
| NCT03481790 | Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy | Iron deficiency anemia | Folic Acid (NPC147983) | NP level |
| NCT00276809 | Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia | chronic lymphocytic leukemia | Etoposide (NPC185498) | NP level |
| NCT01354132 | N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis | mental or behavioural disorder | Acetylcysteine (NPC248970) | NP level |
| NCT00032019 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03451266 | Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia | preeclampsia | Ascorbate (NPC187770) | NP level |
| NCT05389423 | Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas | Burkitts lymphoma;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00000600 | Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up | carotid artery disease;cerebral atherosclerosis;heart disease | Ascorbate (NPC187770) | NP level |
| NCT04981899 | A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01057589 | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | upper aerodigestive tract neoplasm | Folic Acid (NPC147983) | NP level |
| NCT03066778 | A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00012051 | Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002805 | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia | Etoposide (NPC185498) | NP level |
| NCT00863785 | Treatment of Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone | Hepatitis, Alcoholic | Acetylcysteine (NPC248970) | NP level |
| NCT00497328 | COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT | kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00007852 | Rituximab and Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002471 | Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003262 | Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02875457 | Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00589056 | Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002756 | Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02405676 | BNHL-2015 for Children or Adolescents in China | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT00002925 | Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00388856 | Antioxidant Supplementation in Pregnant Women With Low Antioxidant Status | preeclampsia | Ascorbate (NPC187770) | NP level |
| NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT03567642 | A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00098774 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT05245994 | An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04092283 | Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02194049 | Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003602 | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT02780505 | Assessment of the Effect of Vitamin C on Anemia in Patients With Continuous Ambulatory Peritoneal Dialysis | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
| NCT03742115 | Etoposide in the First-line Treatment of Adult EBV-HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT04740021 | Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03450707 | Thiamine as a Metabolic Resuscitator After Cardiac Arrest | cardiac arrest | Thiamine (NPC150950) | NP level |
| NCT02580994 | Pembrolizumab in Untreated Extensive SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03499249 | N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy | biliary atresia | Acetylcysteine (NPC248970) | NP level |
| NCT00809341 | R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00083681 | DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT05468489 | To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04028050 | A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00658580 | Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00612430 | Ph II Bevacizumab + Etoposide for Pts w Recurrent MG | gliosarcoma | Etoposide (NPC185498) | NP level |
| NCT00626444 | Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) | non-Hodgkins lymphoma | Ascorbate (NPC187770) | NP level |
| NCT04478734 | Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease | Huntington disease | Thiamine (NPC150950) | NP level |
| NCT01384591 | Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly | aging | Acetylcysteine (NPC248970) | NP level |
| NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT01873443 | Long-Term Efficacy and Safety of CT-P10 in Patients With RA | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT04501718 | Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT03700359 | A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00136825 | Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1 | cocaine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00002598 | Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02109315 | Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. | type 1 diabetes mellitus | Ascorbate (NPC187770) | NP level |
| NCT00203476 | A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
| NCT03556371 | Evaluation of N-Acetylcysteine Efficacy to Reduce the Craving and to Prolong Abstinence Time of Coca Paste | cocaine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00995085 | Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
| NCT02157792 | M6620 First in Human Study | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00000461 | Harvard Atherosclerosis Reversibility Project (HARP) | Myocardial Ischemia | Niacin (NPC167400) | NP level |
| NCT01852890 | Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | pancreatic neoplasm | Ascorbate (NPC187770) | NP level |
| NCT00006032 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00002642 | SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00072280 | Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT03121989 | Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | breast cancer | Acetylcysteine (NPC248970) | NP level |
| NCT00005802 | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01495260 | A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants | adrenomyeloneuropathy | Acetylcysteine (NPC248970) | NP level |
| NCT04699838 | Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00274807 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00000541 | Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) | myocardial infarction | Folic Acid (NPC147983);Ascorbate (NPC187770);Beta Carotene (NPC17810);Pyridoxine (NPC269919) | NP level |
| NCT01503060 | Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain | pain | Sucrose (NPC130683) | NP level |
| NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01322009 | Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury | brain injury | Acetylcysteine (NPC248970) | NP level |
| NCT04740580 | Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease | Alzheimer disease | Acetylcysteine (NPC248970) | NP level |
| NCT02289690 | Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00791947 | A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT05460858 | NAC Effect on Infertile Women With Endometrioma | female infertility | Acetylcysteine (NPC248970) | NP level |
| NCT00104676 | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors | teratoma;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT03568994 | Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT05009355 | The Effect of Vitamin C on GCF Total Oxidant Capacity in Smoker Patients With Periodontitis | ascorbic acid deficiency | Ascorbate (NPC187770) | NP level |
| NCT00440869 | Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT04945096 | Outcomes of Patients After Allo-HSCT With Decitabine and NAC | graft versus host disease | Acetylcysteine (NPC248970) | NP level |
| NCT00069238 | Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04921189 | Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors | cardiac arrest | Thiamine (NPC150950);Ascorbate (NPC187770) | NP level |
| NCT00026208 | Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00028665 | Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002719 | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01435018 | Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS | HIV-1 infection | Etoposide (NPC185498) | NP level |
| NCT00005780 | Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02934503 | Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02905110 | Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT05485558 | the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy | epilepsy | Acetylcysteine (NPC248970) | NP level |
| NCT01104519 | A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT02262325 | Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01914718 | Dose-adjusted EPOCH-R in MYC Positive DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02688361 | A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution | respiratory tract infectious disorder | Acetylcysteine (NPC248970) | NP level |
| NCT04077905 | Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT03418038 | Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or Clonal Cytopenia of Undetermined Significance | Hodgkins lymphoma | Ascorbate (NPC187770) | NP level |
| NCT00650091 | Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF | pulmonary fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04999137 | Evaluation of Safety and Dosing of a Vitamin C Bundle for Sepsis Treatment in Africa | Sepsis;septic shock | Ascorbate (NPC187770) | NP level |
| NCT00057811 | Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma | anaplastic large cell lymphoma;Burkitts lymphoma;childhood acute lymphoblastic leukemia;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01426438 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | HIV-1 infection | Niacin (NPC167400) | NP level |
| NCT01936831 | High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) | tuberculosis | Pyridoxine (NPC269919) | NP level |
| NCT00023998 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00416832 | Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01722292 | A Study of LY2940680 in Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00216125 | Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04291066 | Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients | brain injury | Acetylcysteine (NPC248970) | NP level |
| NCT00520247 | Effect of Enalapril Plus Folic Acid on Blood Pressure and Glycometabolism | hypertension | Folic Acid (NPC147983) | NP level |
| NCT00376584 | Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) | Disorder of lipid metabolism;hyperlipidemia | Niacin (NPC167400) | NP level |
| NCT00041210 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003421 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT05241262 | Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels | mitochondrial disease | Acetylcysteine (NPC248970) | NP level |
| NCT00554827 | Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma | Cutaneous T-cell lymphoma | Folic Acid (NPC147983) | NP level |
| NCT00031590 | Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00002865 | High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT04422210 | A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002876 | Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT01271088 | Protective Effect of N-acetylcysteine Against From Ototoxicity | hearing loss | Acetylcysteine (NPC248970) | NP level |
| NCT03268733 | The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome | polycystic ovary syndrome | Folic Acid (NPC147983) | NP level |
| NCT03508726 | High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas | soft tissue sarcoma | Ascorbate (NPC187770) | NP level |
| NCT03786783 | Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | ganglioneuroblastoma;neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01232257 | Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD) | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT03623087 | SIMPLE Chemotherapy for NK Lymphoma/Leukaemia | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03592693 | Vitamin C, Hydrocortisone and Thiamine for Septic Shock | septic shock | Ascorbate (NPC187770) | NP level |
| NCT02206425 | Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT05283954 | Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT02631668 | the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
| NCT00332605 | N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence | methamphetamine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT02318446 | Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics | epilepsy | Folic Acid (NPC147983) | NP level |
| NCT00041015 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01187108 | Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru | altitude sickness | Acetylcysteine (NPC248970) | NP level |
| NCT00304070 | Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
| NCT01670955 | The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients | anemia (phenotype) | Folic Acid (NPC147983) | NP level |
| NCT01076231 | Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02636322 | Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002974 | Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00053768 | Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04335084 | A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT03008889 | A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder | autism spectrum disorder | Acetylcysteine (NPC248970) | NP level |
| NCT03991884 | Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00452829 | Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study) | neural tube defect | Folic Acid (NPC147983) | NP level |
| NCT00083551 | UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT03504410 | Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03872011 | Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock | septic shock | Thiamine (NPC150950);Ascorbate (NPC187770) | NP level |
| NCT00288626 | High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study | relapsing-remitting multiple sclerosis | Etoposide (NPC185498) | NP level |
| NCT02870907 | Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT03535961 | Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT01949129 | Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00006487 | S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00667615 | Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00627354 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00003423 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00996424 | The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function | cystic fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT03100955 | A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer | colorectal cancer | Etoposide (NPC185498) | NP level |
| NCT01134861 | Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00000482 | Coronary Drug Project | Myocardial Ischemia;myocardial infarction | Niacin (NPC167400) | NP level |
| NCT00869232 | UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT02356159 | Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation | Hodgkins lymphoma;leukemia;multiple myeloma;myelodysplastic syndrome;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT04516681 | IV Ascorbic Acid in Peritoneal Metastatic Colorectal Cancer | colorectal carcinoma | Ascorbate (NPC187770) | NP level |
| NCT03161054 | Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02443077 | Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT00004031 | SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01210456 | Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00810017 | Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00002657 | SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01681537 | Lenalidomide Plus Chemotherapy for AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT05026593 | A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04951115 | A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05270057 | Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies | Burkitts lymphoma | Etoposide (NPC185498) | NP level |
| NCT00374088 | N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study) | transposition of the great arteries | Acetylcysteine (NPC248970) | NP level |
| NCT03624270 | Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia | acute promyelocytic leukemia | Ascorbate (NPC187770) | NP level |
| NCT00002461 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002494 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT04261036 | Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries | urinary tract infection | Ascorbate (NPC187770) | NP level |
| NCT02424201 | Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja. | postpartum hemorrhage | Ascorbate (NPC187770) | NP level |
| NCT00072384 | Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00002822 | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01490944 | Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls | anemia (phenotype) | Folic Acid (NPC147983) | NP level |
| NCT00061919 | Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03172325 | Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT02969681 | Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer | colorectal neoplasm | Ascorbate (NPC187770) | NP level |
| NCT00098839 | Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) | childhood acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00504751 | Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03517137 | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT05224141 | Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03570983 | A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT03182244 | A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FLT3 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00003957 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04155632 | Neurocircuit Strategy to Decrease Cocaine Cue Reactivity | cocaine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT03188198 | Risk Adapted Therapy in Diffuse Large B Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03887169 | Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. | pulmonary alveolar proteinosis | Folic Acid (NPC147983);Ascorbate (NPC187770);Pyridoxine (NPC269919) | NP level |
| NCT00004128 | Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00392834 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003606 | Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00571493 | VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00000553 | HDL-Atherosclerosis Treatment Study (HATS) | Myocardial Ischemia | Niacin (NPC167400) | NP level |
| NCT00041327 | Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002481 | Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
| NCT03135977 | Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04952051 | Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension | hypertension | Folic Acid (NPC147983) | NP level |
| NCT00002658 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01677949 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00906945 | Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00336024 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma | medulloblastoma;primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
| NCT05363917 | Natrunix Versus Methotrexate in Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT04520074 | Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00534469 | Auto BMT for Non-M3 AML in 1st Remission in Pts | leukemia | Etoposide (NPC185498) | NP level |
| NCT00660036 | Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02949258 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer | gastric cancer | Etoposide (NPC185498) | NP level |
| NCT01190995 | Role of Repeated Painful Procedures in Preterm Neonates on Short Term Neurobehavioural Outcome | pain | Sucrose (NPC130683) | NP level |
| NCT01891747 | A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma | malignant glioma | Ascorbate (NPC187770) | NP level |
| NCT00193596 | Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site | neoplasm | Etoposide (NPC185498) | NP level |
| NCT03328104 | Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | lymphoid leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00903617 | Study to Test GSK256073 in Patients With Dyslipidemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00881166 | Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT00006184 | Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01771978 | Ischaemia-réperfusion During the Coronary Surgery With Beating Heart | ischemia reperfusion injury | Acetylcysteine (NPC248970) | NP level |
| NCT00450801 | R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003625 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00822120 | S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00014313 | Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor | sarcoma | Etoposide (NPC185498) | NP level |
| NCT04928495 | Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19 | COVID-19 | Acetylcysteine (NPC248970);Ascorbate (NPC187770) | NP level |
| NCT04553666 | Reducing Frailty for Older Cancer Survivors Using Supplements | inflammation | Ascorbate (NPC187770) | NP level |
| NCT01675661 | Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment | cannabis dependence | Acetylcysteine (NPC248970) | NP level |
| NCT04665856 | Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01005303 | Micronutrient Supplementation in Patients With Heart Failure | heart failure | Retinol (NPC55412);Ascorbate (NPC187770);Pyridoxine (NPC269919);Folic Acid (NPC147983);Niacin (NPC167400) | NP level |
| NCT01756989 | ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors | glioma | Etoposide (NPC185498) | NP level |
| NCT04594733 | The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia | fibromyalgia | Acetylcysteine (NPC248970) | NP level |
| NCT04254471 | This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00549848 | Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01188876 | Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Folic Acid (NPC147983) | NP level |
| NCT03175341 | Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | breast cancer | Ascorbate (NPC187770) | NP level |
| NCT00552786 | Antioxidation Medication for Noise-induced Hearing Loss | hearing loss | Acetylcysteine (NPC248970) | NP level |
| NCT00005613 | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03980925 | Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. | digestive system neuroendocrine neoplasm | Etoposide (NPC185498) | NP level |
| NCT03794167 | BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00114400 | BVAIT: B-Vitamin Atherosclerosis Intervention Trial | atherosclerosis | Folic Acid (NPC147983);Pyridoxine (NPC269919) | NP level |
| NCT04924101 | Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04370288 | Clinical Application of Methylene Blue for Treatment of Covid-19 Patients | COVID-19 | Ascorbate (NPC187770);Acetylcysteine (NPC248970) | NP level |
| NCT00003397 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00000512 | Familial Atherosclerosis Treatment Study | Myocardial Ischemia | Niacin (NPC167400) | NP level |
| NCT01857934 | Therapy for Children With Advanced Stage Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00967369 | Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT02390505 | Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery | complex regional pain syndrome | Ascorbate (NPC187770) | NP level |
| NCT00047138 | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT00861523 | Does Thiamine Help Vomiting and Nausea in Pregnancy? | hyperemesis gravidarum | Thiamine (NPC150950) | NP level |
| NCT01097057 | Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00005985 | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02212678 | Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease | Parkinson disease | Acetylcysteine (NPC248970) | NP level |
| NCT00002785 | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02762838 | Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00526396 | STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00137995 | R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01092182 | Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma | Burkitts lymphoma;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00500045 | Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions | retinal vein occlusion | Niacin (NPC167400) | NP level |
| NCT00702962 | Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | colorectal neoplasm | Folic Acid (NPC147983) | NP level |
| NCT05289908 | Intrathecal Pemetrexed for Leptomeningeal Metastasis | leptomeningeal metastasis | Folic Acid (NPC147983) | NP level |
| NCT00003631 | Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002936 | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | lymphoma;sarcoma | Etoposide (NPC185498) | NP level |
| NCT00926640 | A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00920153 | Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00630877 | Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00453154 | Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01172275 | N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder | obsessive-compulsive disorder | Acetylcysteine (NPC248970) | NP level |
| NCT00003346 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | cutaneous melanoma | Acetylcysteine (NPC248970) | NP level |
| NCT00006374 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02768558 | Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05466318 | ChiCGB vs BEAM in High-risk or R/R Lymphomas | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00916669 | A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01178658 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03628131 | Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00965653 | A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00024310 | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Folic Acid (NPC147983) | NP level |
| NCT04765098 | Tamoxifen Versus Etoposide After First Recurrence in GBM Patients | glioblastoma multiforme | Etoposide (NPC185498) | NP level |
| NCT05142696 | A Safety Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) Patients in Combination With Carboplatin, Etoposide and Tislelizumab | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00109928 | S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04712435 | Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation | hepatic veno-occlusive disease | Acetylcysteine (NPC248970) | NP level |
| NCT00218491 | Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1 | cocaine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT01857453 | Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00025623 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00004906 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00084838 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT05076786 | Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT01017796 | Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients | kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT03680911 | NAC for Head Trauma-induced Anosmia | injury | Acetylcysteine (NPC248970) | NP level |
| NCT01329900 | Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04404387 | Lessening Organ Dysfunction With VITamin C in Septic ARDS | acute respiratory distress syndrome | Ascorbate (NPC187770) | NP level |
| NCT00131027 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03321890 | Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02420314 | Pharmacological Ascorbate for Lung Cancer | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
| NCT00515138 | A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant | lymphoma | Etoposide (NPC185498) | NP level |
| NCT05340504 | Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder | bipolar I disorder | Acetylcysteine (NPC248970) | NP level |
| NCT00372593 | Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03510884 | An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT02080182 | Effect of Acetylcysteine in Pediatric Acute Pyelonephritis. | pyelonephritis | Acetylcysteine (NPC248970) | NP level |
| NCT00568464 | Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) | Ewing sarcoma | Etoposide (NPC185498) | NP level |
| NCT05096663 | Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
| NCT00002557 | Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01222572 | Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01118663 | Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection | drug-induced liver injury | Acetylcysteine (NPC248970) | NP level |
| NCT00878449 | A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer | neoplasm | Etoposide (NPC185498) | NP level |
| NCT02661503 | HD21 for Advanced Stages | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005589 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00734877 | UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00005823 | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
| NCT01590303 | Outcome Following Vitamin C Administration in Sepsis | Sepsis | Ascorbate (NPC187770) | NP level |
| NCT00049218 | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00003597 | Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT00763633 | B6 Treatment for Nausea and Vomiting in Pregnancy | Nausea and vomiting | Pyridoxine (NPC269919) | NP level |
| NCT02748889 | Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00006695 | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00812266 | Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00303849 | Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors | anaplastic oligodendroglioma | Etoposide (NPC185498) | NP level |
| NCT01800526 | A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease | sickle cell anemia | Acetylcysteine (NPC248970) | NP level |
| NCT02639650 | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor | gestational trophoblastic neoplasm | Etoposide (NPC185498) | NP level |
| NCT00002854 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer | cancer | Etoposide (NPC185498) | NP level |
| NCT00002788 | High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00780962 | N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients | kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00002521 | Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00187083 | A Study of Children With Refractory or Relapsed ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00005977 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT04356690 | Etoposide in Patients With COVID-19 Infection | COVID-19 | Etoposide (NPC185498) | NP level |
| NCT00005612 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00002798 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;chronic myelomonocytic leukemia;refractory anemia;refractory anemia with excess blasts | Etoposide (NPC185498) | NP level |
| NCT05008224 | Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00567567 | Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02227199 | Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00276731 | Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04900792 | A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
| NCT00003284 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01415765 | MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01580683 | Vitamin C and Atrial Fibrillation After Cardiac Surgery | atrial fibrillation | Ascorbate (NPC187770) | NP level |
| NCT05494398 | Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label | autism spectrum disorder | Acetylcysteine (NPC248970) | NP level |
| NCT01180322 | Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00003389 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00611000 | Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia | colorectal carcinoma | Folic Acid (NPC147983) | NP level |
| NCT00572169 | UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00299104 | A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT03944772 | Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01775475 | Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT02702492 | PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA) | non-Hodgkins lymphoma | Niacin (NPC167400) | NP level |
| NCT04622228 | Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00943124 | MK0524B Bioequivalence Study (0524B-070) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00017251 | Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01217814 | Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT02653196 | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors | neuroepithelial neoplasm | Etoposide (NPC185498) | NP level |
| NCT00028769 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00878254 | Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00329498 | L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | acute myeloid leukemia;myelodysplastic syndrome | Ascorbate (NPC187770) | NP level |
| NCT00016887 | Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00299130 | A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT01061736 | Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00682981 | A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02359162 | Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02771743 | Response-based Treatment of High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00406874 | Effect of Omega 3 Fats on Sperm Quality and Sexual Function | infertility | Folic Acid (NPC147983) | NP level |
| NCT00349778 | High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT04363216 | Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT00002517 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00001563 | EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT03090048 | Vitamin A and Azithromycin for Acne Vulgaris | acne | Retinol (NPC55412) | NP level |
| NCT00439556 | Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00933673 | New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00924209 | A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00100477 | Use of Topotecan in Patients With Refractory Acute Leukemia | leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002912 | Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01993810 | Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01908452 | Pyridoxal Kinase Activity in Tardive Dyskinesia | movement disorder | Pyridoxine (NPC269919) | NP level |
| NCT00632827 | Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03720483 | Inhaled NAC in Treatment of IPF | idiopathic pulmonary fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT00017368 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00002514 | Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission | leukemia | Etoposide (NPC185498) | NP level |
| NCT01172288 | N-acetylcysteine (NAC) for Children With Tourette Syndrome | Tourette syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT00379457 | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT02912702 | L-DEP as an Initial Treatment for EBV-HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT02722369 | STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02861573 | Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT02815592 | Trial of BMS-986012 in Combination With Platinum and Etoposide | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01237808 | Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01573338 | Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00109031 | Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) | leukemia;lymphoma;cancer | Etoposide (NPC185498) | NP level |
| NCT00864318 | Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT04002947 | Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002567 | High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission | leukemia | Etoposide (NPC185498) | NP level |
| NCT01331590 | Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03723941 | Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
| NCT00958022 | Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04154189 | A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00618501 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01752491 | A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
| NCT01537926 | Hypertrophic Regression With N-Acetylcysteine in HCM | hypertrophic cardiomyopathy | Acetylcysteine (NPC248970) | NP level |
| NCT00484510 | High Dose Ascorbic Acid Treatment of CMT1A | Charcot-Marie-Tooth disease type 1A | Ascorbate (NPC187770) | NP level |
| NCT02701673 | Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma | lymphoma | Pyridoxine (NPC269919) | NP level |
| NCT02329080 | New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005090 | S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00998972 | N-acetyl-cysteine (NAC) and Kidney Graft Function | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00184054 | Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia | acute myeloid leukemia | Ascorbate (NPC187770) | NP level |
| NCT00043979 | Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | sarcoma | Etoposide (NPC185498) | NP level |
| NCT02493933 | Phytoestrogen, NO Donors, N-acetyl Cysteine Add Therapy to Clomiphene Citrate to Improve Pregnancy Rate in PCO Patients | infertility | Acetylcysteine (NPC248970) | NP level |
| NCT00002926 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00025272 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00536510 | Effect of MK0524A on Cholesterol Levels (0524A-048) | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
| NCT03860844 | Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00004224 | Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00004176 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00114738 | EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00691210 | Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies | Hodgkins lymphoma;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00742924 | Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00676195 | An Open-Label Study of N-Acetyl Cysteine in Children With Autism | autism | Acetylcysteine (NPC248970) | NP level |
| NCT03432598 | Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02137928 | Carboplatin Periocular Injection for Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT04730999 | Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00616785 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01450761 | Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00780104 | Sirolimus in Combination With MEC in High Risk Myeloid Leukemias | chronic myelogenous leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04920448 | N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE | stroke | Acetylcysteine (NPC248970) | NP level |
| NCT03685773 | The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
| NCT03272594 | The Influence of Breastfeeding on Cortical Activity During Procedures | pain | Sucrose (NPC130683) | NP level |
| NCT00734695 | Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment. | burn | Ascorbate (NPC187770) | NP level |
| NCT04326439 | AflacLL1901 (CHOA-AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04154982 | N-Acetylcysteine Protection Against Radiation Induced Cellular Damage | cardiac arrhythmia | Acetylcysteine (NPC248970) | NP level |
| NCT02344355 | A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
| NCT01920932 | Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00695409 | Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03164421 | N-Acetylcysteine and L-carnitine in Pcos | polycystic ovary syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT00003937 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT01905150 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
| NCT02018861 | A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) | cancer | Etoposide (NPC185498) | NP level |
| NCT00264953 | HD11 for Intermediate Stages | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005834 | S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00006040 | Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
| NCT00880243 | Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00003364 | Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01604863 | A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies | cancer | Etoposide (NPC185498) | NP level |
| NCT01840566 | High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00613457 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02166463 | Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00426101 | Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00427791 | Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03061656 | Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00003141 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors | brain neoplasm;neuroblastoma;sarcoma | Etoposide (NPC185498) | NP level |
| NCT05142865 | Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT03101579 | Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer | leptomeningeal metastasis | Folic Acid (NPC147983) | NP level |
| NCT03702738 | Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis | tuberculosis | Acetylcysteine (NPC248970) | NP level |
| NCT00003650 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00025649 | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04557215 | Efficacy and Safety of Rifaximin With NAC in IBS-D | irritable bowel syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT02632708 | Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01899066 | Efficacy Study of Lucentis in the Treatment of Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00002590 | Combination Chemotherapy in Treating Children With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00049036 | Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT00003621 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00040872 | Multiple Therapies in Treating Patients With Advanced Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00269204 | Lipid Efficacy/Tolerability Study (0524A-020) | Combined hyperlipidemia | Niacin (NPC167400) | NP level |
| NCT00240097 | Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01356290 | Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT05353257 | A Study to Evaluate the Efficacy and Safety of HLX10 in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03510715 | An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT00186966 | Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00578305 | A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00000161 | Randomized Trials of Vitamin Supplements and Eye Disease | macular degeneration | Ascorbate (NPC187770);Beta Carotene (NPC17810) | NP level |
| NCT00514540 | Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00005022 | Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002550 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00334867 | Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00791154 | QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03458260 | Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03382561 | Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01030900 | Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas | diffuse large B-cell lymphoma;Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003436 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT04347889 | Preventing COVID-19 in Healthcare Workers With HCQ: A RCT | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT05361395 | First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003309 | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT02631109 | L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT01194453 | Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
| NCT01300793 | Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide | neoplasm of mature B-cells;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Etoposide (NPC185498) | NP level |
| NCT01321034 | Effect of Niacin in the Lipoprotein (a) Concentration | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT00187005 | Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT05384015 | Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00325572 | Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism | autism | Ascorbate (NPC187770) | NP level |
| NCT03206671 | Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT02505087 | Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM) | myopathy | Acetylcysteine (NPC248970) | NP level |
| NCT00057837 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002691 | Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00949104 | Role of Oral Sucrose in Reducing the Pain to Orogastric Tube Insertion in Preterm Neonates | pain | Sucrose (NPC130683) | NP level |
| NCT00250718 | Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03216954 | Influence of n-Acetylcysteine Maintenance on Alcohol Effects | alcohol dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00391911 | Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis | rhabdomyolysis | Acetylcysteine (NPC248970) | NP level |
| NCT02504359 | Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma | plasma cell leukemia;multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT04035096 | The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients | malignant colon neoplasm | Ascorbate (NPC187770) | NP level |
| NCT04322318 | A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT | kidney Wilms tumor | Etoposide (NPC185498) | NP level |
| NCT00005998 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00568087 | N-acetylcysteine in Alcohol Dependence | alcohol dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00209833 | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T | refractory anemia | Etoposide (NPC185498) | NP level |
| NCT00034463 | ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer | cancer | Folic Acid (NPC147983) | NP level |
| NCT03023046 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006122 | Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00080886 | Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04989283 | Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00216099 | Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer | prostate cancer | Folic Acid (NPC147983) | NP level |
| NCT00639496 | Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) | pulmonary fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT03586999 | Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04490421 | Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02795299 | Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT02794571 | Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT03117751 | Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT02994875 | Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence | cocaine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT02107976 | Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes | diabetes mellitus | Ascorbate (NPC187770) | NP level |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01116141 | A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT01859741 | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04696575 | Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00661544 | Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT03252925 | A Safety and Efficacy Study of NAC in Patients With TA-TMA | Abnormality of blood and blood-forming tissues | Acetylcysteine (NPC248970) | NP level |
| NCT00151242 | Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00493064 | To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions | retinal vein occlusion | Niacin (NPC167400) | NP level |
| NCT00470223 | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT04101357 | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02750319 | Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery | atrial fibrillation | Acetylcysteine (NPC248970) | NP level |
| NCT05081479 | A Study of N-Acetylcysteine (N-AC)in People Receiving CAR T-cell Therapy for Lymphoma | lymphoma | Acetylcysteine (NPC248970) | NP level |
| NCT00975689 | Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine | Niemann-Pick disease type C | Acetylcysteine (NPC248970) | NP level |
| NCT00003583 | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00003859 | Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00993265 | N-Acetylcysteine for Pediatric Trichotillomania | Hair-pulling | Acetylcysteine (NPC248970) | NP level |
| NCT01830777 | Brentuximab Vedotin + Re-induction Chemotherapy for AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00133419 | Micronutrients and Enteric Infections in African Children | infection | Retinol (NPC55412) | NP level |
| NCT00039195 | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00052923 | Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00315705 | A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00002488 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003401 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT02189772 | Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
| NCT00005867 | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02940990 | SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04012606 | Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03636932 | RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT02523976 | Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | lymphoid leukemia | Etoposide (NPC185498) | NP level |
| NCT02393378 | Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00253435 | N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04368598 | The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP | autoimmune thrombocytopenic purpura | Acetylcysteine (NPC248970) | NP level |
| NCT00204646 | Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | sarcoma | Etoposide (NPC185498) | NP level |
| NCT02070458 | Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00630565 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00504140 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00641381 | Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003194 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00040690 | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT04405193 | The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms | methamphetamine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT02502708 | Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors | gliosarcoma;ependymoma;medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT00002836 | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT01055314 | Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma | alveolar rhabdomyosarcoma;embryonal rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT01878669 | Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention | coronary artery disease | Acetylcysteine (NPC248970) | NP level |
| NCT00002675 | Chemotherapy in Treating Patients With Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT01356680 | HD17 for Intermediate Stage Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00554463 | G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00080275 | Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT02225886 | Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
| NCT04996771 | Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01873326 | Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT05122559 | Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis | chronic progressive multiple sclerosis | Acetylcysteine (NPC248970) | NP level |
| NCT00151060 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT01032070 | Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma | childhood ependymoma | Etoposide (NPC185498) | NP level |
| NCT00804843 | Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) | carotid atherosclerosis | Niacin (NPC167400) | NP level |
| NCT03213977 | R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02773147 | Effect of Vitamin B on Plasma Neurofilament Light Protein (NFL) in HIV-infected Individuals With Increased Plasma Homocysteine | HIV infection | Folic Acid (NPC147983);Pyridoxine (NPC269919) | NP level |
| NCT00274924 | Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01753752 | Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation | dry eye syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT00728910 | Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT01587261 | Vitamin C for Severe Thermal Injuries | injury | Ascorbate (NPC187770) | NP level |
| NCT00186875 | Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00726986 | Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT05453500 | Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00004903 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00499616 | Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02109614 | Early Aortic Valve Lipoprotein(a) Lowering Trial | aortic stenosis | Niacin (NPC167400) | NP level |
| NCT03866174 | A Study of Psilocybin for Major Depressive Disorder (MDD) | major depressive disorder | Niacin (NPC167400) | NP level |
| NCT03613597 | Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02723162 | Translational Neuropsychopharmacology Research of Nicotine Addiction | nicotine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00003967 | Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | fallopian tube cancer;peritoneum cancer;ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00004898 | Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT04551131 | Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00483561 | Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT00562978 | Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004186 | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00033722 | Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | lung cancer | Folic Acid (NPC147983) | NP level |
| NCT00000541 | Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) | Myocardial Ischemia | Ascorbate (NPC187770) | NP level |
| NCT00002688 | Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03679442 | Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol Overdose | injury | Acetylcysteine (NPC248970) | NP level |
| NCT00655928 | Modulation of Lung Injury Complicating Lung Resection | acute lung injury | Acetylcysteine (NPC248970) | NP level |
| NCT03923179 | Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT02836639 | BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003380 | Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | fallopian tube cancer;peritoneum cancer;ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00133406 | Long-term Impact and Intervention for Diarrhea in Brazil | diarrheal disease | Retinol (NPC55412) | NP level |
| NCT00002768 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission | leukemia | Etoposide (NPC185498) | NP level |
| NCT00217503 | Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03793478 | Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04278898 | Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose | autism spectrum disorder | Acetylcysteine (NPC248970) | NP level |
| NCT00002802 | Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00003402 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT03769935 | Maintenance Therapy for Small-cell Lung Cancer | colorectal cancer | Etoposide (NPC185498) | NP level |
| NCT03059667 | Immunotherapy as Second-line in Patient With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01457040 | Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00606502 | Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
| NCT00002650 | High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed | colorectal carcinoma | Folic Acid (NPC147983) | NP level |
| NCT02734147 | High Dose Intravenous Ascorbic Acid in Severe Sepsis | Sepsis | Ascorbate (NPC187770) | NP level |
| NCT00732498 | Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00298272 | Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT01226849 | Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002827 | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00058292 | Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00717938 | A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00300365 | Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL | metabolic syndrome | Niacin (NPC167400) | NP level |
| NCT00830193 | N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography | kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00002697 | Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03799094 | Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
| NCT00568607 | Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002766 | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT02379091 | Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT02848183 | Optimal Treatment Strategy Based on for Pediatric AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00666484 | Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02337712 | Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04638790 | First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00120822 | Folic Acid Supplementation in Gambian Primigravidae | malaria | Folic Acid (NPC147983) | NP level |
| NCT04900415 | Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction | COVID-19 | Retinol (NPC55412) | NP level |
| NCT00379340 | Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | Wilms tumor | Etoposide (NPC185498) | NP level |
| NCT00003573 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00003113 | Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02039726 | (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03148236 | Vitamin C in Atrial Fibrillation Ablation | atrial fibrillation | Ascorbate (NPC187770) | NP level |
| NCT02947113 | Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02595424 | Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery | pancreatic endocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002549 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00211562 | Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids | schizophrenia | Ascorbate (NPC187770) | NP level |
| NCT02878265 | The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian Children | malaria | Retinol (NPC55412) | NP level |
| NCT01733589 | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00387868 | Preoperative Treatment of Patients With High Risk Thymoma | Thymoma | Etoposide (NPC185498) | NP level |
| NCT03745963 | The Influence of Skin-to-skin Contact on Cortical Activity During Painful Procedures on Preterm Infants in the NICU | pain | Sucrose (NPC130683) | NP level |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04189094 | Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00054665 | PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT00005863 | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
| NCT05161533 | Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00970385 | Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00751257 | N-Acetylcysteine and Smoking Reduction | nicotine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT02737358 | N-acetylcysteine for Tobacco Use Disorder | nicotine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00470522 | Study of Methotrexate in Lupus Erythematosus | systemic lupus erythematosus | Folic Acid (NPC147983) | NP level |
| NCT01887340 | Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma | seminoma | Etoposide (NPC185498) | NP level |
| NCT02294591 | NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression | bipolar disorder | Acetylcysteine (NPC248970) | NP level |
| NCT00049595 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01468740 | Prospective Study on HIV-related Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00052299 | Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00508989 | Niacin to Improve Blood Flow in People With Sickle Cell Disease | sickle cell anemia | Niacin (NPC167400) | NP level |
| NCT02408042 | Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) | Hodgkins lymphoma;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01117441 | International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02987244 | Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00826644 | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04675697 | Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03063021 | The FIGHT-RP1 Study | retinitis pigmentosa | Acetylcysteine (NPC248970) | NP level |
| NCT03839446 | Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00022737 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | childhood acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00004006 | Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT04061772 | A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00271817 | To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT00004907 | Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04221035 | High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00521014 | GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02066688 | Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer | colorectal neoplasm | Folic Acid (NPC147983) | NP level |
| NCT00011921 | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00749723 | Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT04630964 | The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density | major depressive disorder | Niacin (NPC167400) | NP level |
| NCT00002887 | Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002987 | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03066115 | Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow Regulation | hypoxia | Ascorbate (NPC187770) | NP level |
| NCT03168594 | Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | gastric cancer | Ascorbate (NPC187770) | NP level |
| NCT00439361 | Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00416676 | Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00002610 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT00187161 | Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT02341989 | Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | seminoma;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT00004905 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00135135 | Therapy for Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01046825 | Mature B-Cell Lymphoma And Leukemia Study III | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004086 | Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT01238471 | Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study | retinopathy of prematurity | Sucrose (NPC130683) | NP level |
| NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01381354 | Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) | multiple sclerosis | Thiamine (NPC150950) | NP level |
| NCT00126191 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | Burkitts lymphoma | Etoposide (NPC185498) | NP level |
| NCT00025402 | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002714 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02633514 | Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma | thymus neoplasm | Etoposide (NPC185498) | NP level |
| NCT00000541 | Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) | Myocardial Ischemia | Pyridoxine (NPC269919);Folic Acid (NPC147983);Beta Carotene (NPC17810) | NP level |
| NCT01885338 | N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia | schizophrenia | Acetylcysteine (NPC248970) | NP level |
| NCT05284656 | Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease | chronic kidney disease | Folic Acid (NPC147983) | NP level |
| NCT05294055 | Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00003053 | Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02114502 | Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | multiple myeloma | Pyridoxine (NPC269919) | NP level |
| NCT00137111 | Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01906814 | Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00025064 | Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04481048 | Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1 | neurofibromatosis type 1 | Acetylcysteine (NPC248970) | NP level |
| NCT04684017 | Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04234607 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01064466 | Pharmacogenomics IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02553460 | Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00559104 | Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00317811 | Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT04732000 | Oxidative Stress and Surgical Recovery | pain | Acetylcysteine (NPC248970) | NP level |
| NCT00162695 | Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT01251107 | Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01864109 | Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma | Ewing sarcoma | Etoposide (NPC185498) | NP level |
| NCT04440280 | Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy | Fuchs endothelial corneal dystrophy | Acetylcysteine (NPC248970) | NP level |
| NCT00079105 | A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02602483 | Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD). | temporomandibular joint disorder | Ascorbate (NPC187770) | NP level |
| NCT02516670 | Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer | metastatic prostate cancer | Ascorbate (NPC187770) | NP level |
| NCT01243242 | Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD) | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
| NCT04357782 | Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation | hypoxia;COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT05116007 | Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002945 | High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | chronic lymphocytic leukemia;diffuse large B-cell lymphoma;Hodgkins lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00672360 | Folate Rechallenge | autism | Folic Acid (NPC147983) | NP level |
| NCT00352027 | Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002532 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00025259 | Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT01165021 | A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
| NCT05123365 | An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms | essential thrombocythemia;myelofibrosis;polycythemia vera | Acetylcysteine (NPC248970) | NP level |
| NCT04778410 | Study of Magrolimab Combinations in Participants With Myeloid Malignancies | cancer | Etoposide (NPC185498) | NP level |
| NCT02583672 | Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1) | Gaucher disease type 1 | Acetylcysteine (NPC248970) | NP level |
| NCT00005793 | A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide | leukemia | Etoposide (NPC185498) | NP level |
| NCT01828437 | Addition of Pyridoxine to Prednisolone in Infantile Spasms | West syndrome | Pyridoxine (NPC269919) | NP level |
| NCT00136188 | Nitric Oxide (NO) Activity and Diabetic Nephropathy | diabetic nephropathy | Folic Acid (NPC147983) | NP level |
| NCT02040818 | Treatment of Hemodialysis Catheter-Related Bacteremia | bacteriemia | Acetylcysteine (NPC248970) | NP level |
| NCT01481272 | Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00482560 | Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening | pain | Sucrose (NPC130683) | NP level |
| NCT04745689 | Study of AZD2811 + Durvalumab in ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01976676 | Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion | habitual abortion | Folic Acid (NPC147983) | NP level |
| NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00008190 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00968760 | CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
| NCT01987232 | Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03564704 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT04312594 | Jaktinib Dihydrochloride Monohydrate in Idiopathic Pulmonary Fibrosis | idiopathic pulmonary fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT02908581 | Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis | heavy metal poisoning | Folic Acid (NPC147983) | NP level |
| NCT00577629 | Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00120289 | Niacin Plus Statin to Prevent Vascular Events | stroke;atherosclerosis;myocardial infarction | Niacin (NPC167400) | NP level |
| NCT03164057 | A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT02106650 | Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies | unspecified peripheral T-cell lymphoma | Folic Acid (NPC147983) | NP level |
| NCT00002565 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00067899 | Oxidative Stress and Vitamin E Requirements | nicotine dependence | Ascorbate (NPC187770) | NP level |
| NCT00712582 | Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02793648 | Effectiveness of Ascorbic Acid and Tocopherol for Depression in Elderly. | depressive disorder | Ascorbate (NPC187770) | NP level |
| NCT04832009 | Reversing Glucose and Lipid-mediated Vascular Dysfunction | hypertension | Ascorbate (NPC187770) | NP level |
| NCT05354700 | A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00024193 | Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01258634 | A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT00000114 | Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa | retinitis pigmentosa | Retinol (NPC55412) | NP level |
| NCT04381897 | Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome | Cornelia de Lange syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT00004110 | Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00180908 | Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT03781869 | Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01063439 | BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00271635 | Ascorbic Acid Treatment in CMT1A Trial (AATIC) | Charcot-Marie-Tooth disease | Ascorbate (NPC187770) | NP level |
| NCT00006045 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00796887 | Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery | Ischemic stroke | Niacin (NPC167400) | NP level |
| NCT00004758 | Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment | epilepsy | Pyridoxine (NPC269919) | NP level |
| NCT00054938 | Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) | systemic lupus erythematosus | Folic Acid (NPC147983) | NP level |
| NCT01563601 | Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02379637 | Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough | common cold | Acetylcysteine (NPC248970) | NP level |
| NCT02467504 | Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00720109 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00781196 | Folic Acid Supplementation in Phenytoin Induced Gingival Overgrowth | gingival overgrowth | Folic Acid (NPC147983) | NP level |
| NCT03901118 | Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT02298283 | Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03418038 | Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or Clonal Cytopenia of Undetermined Significance | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00611897 | N-acetylcysteine and NMDA Antagonist Interactions | Cognitive impairment | Acetylcysteine (NPC248970) | NP level |
| NCT00936156 | Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years | primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
| NCT02899728 | Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01797575 | N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder | bipolar disorder | Acetylcysteine (NPC248970) | NP level |
| NCT03553238 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03389087 | Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00716066 | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | chronic inflammatory demyelinating polyneuropathy;Myasthenia gravis;neuromyelitis optica;Opsoclonus-Myoclonus Syndrome;Stiff-Person syndrome | Etoposide (NPC185498) | NP level |
| NCT02699099 | Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. | malaria | Retinol (NPC55412) | NP level |
| NCT00324298 | Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles | testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT02626338 | Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01470027 | N-Acetylcysteine for Neuroprotection in Parkinson's Disease | Parkinson disease | Acetylcysteine (NPC248970) | NP level |
| NCT05006664 | Brentuximab Vedotin in Combination With CHEP in Patient With PTCL | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00378833 | Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
| NCT00609102 | Antioxidant Treatment of Type 2 Diabetes | type 2 diabetes mellitus | Acetylcysteine (NPC248970) | NP level |
| NCT04542369 | Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01783535 | Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00086944 | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00000116 | Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A | retinitis pigmentosa | Retinol (NPC55412) | NP level |
| NCT02563327 | Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis | tuberculosis | Pyridoxine (NPC269919) | NP level |
| NCT04624204 | Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05221645 | Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01871766 | Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT01653418 | Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01115504 | Thiamine Supplementation in Heart Failure Patients Receiving Full Medical Therapy | heart failure | Thiamine (NPC150950) | NP level |
| NCT00472056 | Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01583647 | A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) | familial hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT04472949 | Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01118624 | Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer | breast carcinoma | Folic Acid (NPC147983) | NP level |
| NCT03349346 | Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005946 | Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation | leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00397657 | Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis | atherosclerosis | Niacin (NPC167400) | NP level |
| NCT01741207 | Effect of N-acetylcystein in Myocardial Infarction | acute myocardial infarction | Acetylcysteine (NPC248970) | NP level |
| NCT02631239 | MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04046094 | Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients | urinary bladder cancer | Ascorbate (NPC187770) | NP level |
| NCT00083161 | Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT05364424 | A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00203099 | Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine | multiple sclerosis | Acetylcysteine (NPC248970) | NP level |
| NCT00007865 | Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02773732 | Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03792815 | Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL) | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT04783792 | The Effect of Phenolic Compounds in Osteoarthritis; a Nutritional Intervention | osteoarthritis | Ascorbate (NPC187770) | NP level |
| NCT00388349 | Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006708 | S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03581773 | Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy | mucositis | Folic Acid (NPC147983) | NP level |
| NCT00274950 | Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | childhood germ cell tumor;ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00512252 | AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00539500 | Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00058461 | Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | Burkitts lymphoma;diffuse large B-cell lymphoma;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT01364805 | New Treatment Option for Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
| NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19;influenza;pneumonia | Ascorbate (NPC187770) | NP level |
| NCT05092412 | Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03707951 | N-Acetylcysteine for Adolescent Alcohol Use Disorder | alcohol dependence | Acetylcysteine (NPC248970) | NP level |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01979536 | Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma | anaplastic large cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01849016 | N-Acetylcysteine in Patients With Sickle Cell Disease | sickle cell anemia | Acetylcysteine (NPC248970) | NP level |
| NCT00002531 | Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00556127 | Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002961 | Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00401609 | G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04878016 | A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03118466 | Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03437902 | Impact of Rutin and Vitamin C Combination on Oxidative Stress, Insulin Sensitivity and Lipid Profile in Type 2 Diabetic Patients | type 2 diabetes mellitus | Ascorbate (NPC187770) | NP level |
| NCT00003119 | Surgery in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01900509 | Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies | Hodgkins lymphoma;leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02845882 | LBL-2016 for Children or Adolescents in China | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT02176967 | Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | ganglioneuroblastoma;neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01178645 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03755804 | Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01294670 | Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00005631 | Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03736616 | Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002835 | Combination Chemotherapy in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01201954 | Pain Relief of Newborn Preterm Infants During Endotracheal Suctioning | pain | Sucrose (NPC130683) | NP level |
| NCT04268849 | Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient | Iron deficiency anemia | Ascorbate (NPC187770) | NP level |
| NCT01055301 | S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01451515 | NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT01005303 | Micronutrient Supplementation in Patients With Heart Failure | heart failure | Thiamine (NPC150950) | NP level |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00573690 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT03223519 | COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS) | muscular disease | Ascorbate (NPC187770) | NP level |
| NCT00085098 | Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT02868151 | Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers | oral mucositis | Ascorbate (NPC187770) | NP level |
| NCT04703361 | Effects of Ketones and Niacin in Heart Failure Patients | systolic heart failure | Niacin (NPC167400) | NP level |
| NCT05298423 | Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03596125 | Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP) | premature birth | Acetylcysteine (NPC248970) | NP level |
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT02412267 | Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00803530 | Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes | myelodysplastic syndrome | Ascorbate (NPC187770) | NP level |
| NCT02606773 | "Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects | ascorbic acid deficiency | Ascorbate (NPC187770) | NP level |
| NCT01154439 | Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02791906 | Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease | chronic kidney disease | Ascorbate (NPC187770) | NP level |
| NCT02297399 | Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients | diabetes mellitus | Ascorbate (NPC187770) | NP level |
| NCT02499770 | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00218946 | Nasogastric Tube in Premature Babies - Pain and Treatment | premature birth | Sucrose (NPC130683) | NP level |
| NCT01985685 | The Effect of Thiamine vs. Placebo on VO2 in Critical Illness | respiratory failure | Thiamine (NPC150950) | NP level |
| NCT02867956 | Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00575419 | Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure | kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00002571 | SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT00798148 | 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00003158 | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT05058651 | Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung | small cell carcinoma | Etoposide (NPC185498) | NP level |
| NCT03617432 | Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients | neoplasm | Etoposide (NPC185498) | NP level |
| NCT02655913 | Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
| NCT01685281 | Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
| NCT04702880 | A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00720447 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00176605 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT02825147 | Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02013362 | Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Folic Acid (NPC147983) | NP level |
| NCT01502280 | Fluorescence-guided Surgery for Low- and High-grade Gliomas | glioma | Ascorbate (NPC187770) | NP level |
| NCT05484583 | Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04923776 | Liver Directed RT + Chemo-immunotherapy for ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03120468 | Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder | alcohol dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00006012 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00025363 | Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
| NCT00128557 | Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh | vitamin A deficiency | Retinol (NPC55412) | NP level |
| NCT01096368 | Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | anaplastic ependymoma | Etoposide (NPC185498) | NP level |
| NCT02174705 | Rotavirus vs. Sucrose for Vaccine Injection Pain | pain | Sucrose (NPC130683) | NP level |
| NCT00569985 | Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04346914 | Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03843541 | A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions | respiratory system disease | Acetylcysteine (NPC248970) | NP level |
| NCT00193531 | Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT00039130 | Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT02385110 | Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis | leukemia | Etoposide (NPC185498) | NP level |
| NCT00047281 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00324467 | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | neoplasm of mature B-cells;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00262210 | A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00984997 | Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00809094 | NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients | cystic fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT03241472 | Induction of Ovulation Using Clomiphene Citrate and N-acetyl Cysteine Versus Letrozole | infertility | Acetylcysteine (NPC248970) | NP level |
| NCT02141620 | n-Acetylcysteine and Cocaine | cocaine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00351195 | Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Etoposide (NPC185498) | NP level |
| NCT03862586 | NAC Effect on Hox Genes Expressions in RIF | female infertility | Acetylcysteine (NPC248970) | NP level |
| NCT04756622 | N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. | mucositis | Acetylcysteine (NPC248970) | NP level |
| NCT04543890 | A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003815 | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02961816 | Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma | lymphoma | Pyridoxine (NPC269919) | NP level |
| NCT00392886 | Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00003696 | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01818908 | Trial of DA-EPOCH Regimen for NHL With HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00073918 | Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | anaplastic large cell lymphoma;MALT lymphoma;Waldenstrom macroglobulinemia;Burkitts lymphoma;diffuse large B-cell lymphoma;follicular lymphoma;lymphoblastic lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01878695 | Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer | breast cancer | Acetylcysteine (NPC248970) | NP level |
| NCT02259595 | Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC | noise-induced hearing loss | Acetylcysteine (NPC248970) | NP level |
| NCT00554788 | Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT00367497 | Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01368328 | Effect of the Chromium Nicotinate on Type 2 Diabetes | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
| NCT02890992 | An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT02582697 | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT01587963 | High Dose Vitamin C in the Critically Ill Patient | Shock | Ascorbate (NPC187770) | NP level |
| NCT04344184 | SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI) | acute lung injury;COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003728 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT00033696 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00186888 | Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT03064867 | Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01506765 | Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia | schizophrenia | Acetylcysteine (NPC248970) | NP level |
| NCT03333278 | The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial | Sepsis;septic shock | Ascorbate (NPC187770);Thiamine (NPC150950) | NP level |
| NCT05091567 | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00485758 | Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069) | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
| NCT00855257 | Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome | acute coronary syndrome | Niacin (NPC167400) | NP level |
| NCT00384293 | Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) | familial hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT01746173 | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | T-cell non-Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT04256421 | A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01715597 | Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma | uterine fibroid | Ascorbate (NPC187770) | NP level |
| NCT01071525 | The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT00006373 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02518750 | Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT01080352 | Vitamin C as an Anti-cancer Drug | prostate adenocarcinoma | Ascorbate (NPC187770) | NP level |
| NCT00273702 | An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling | gambling behaviour | Acetylcysteine (NPC248970) | NP level |
| NCT04023266 | A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI | ST Elevation Myocardial Infarction | Acetylcysteine (NPC248970) | NP level |
| NCT00272610 | Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin | Purpura | Retinol (NPC55412) | NP level |
| NCT00003860 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04560972 | LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02372409 | Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors | anaplastic astrocytoma;glioblastoma multiforme;oligoastrocytoma;oligodendroglioma;optic nerve glioblastoma;pilocytic astrocytoma | Etoposide (NPC185498) | NP level |
| NCT00398554 | Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03540758 | Regulation of Endogenous Glucose Production by Central KATP Channels | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
| NCT00150722 | High-Density Lipoprotein (HDL) Modulation and Endothelial Function | atherosclerosis | Niacin (NPC167400) | NP level |
| NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | colorectal cancer | Folic Acid (NPC147983) | NP level |
| NCT05309629 | Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00631111 | Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain | pain | Ascorbate (NPC187770) | NP level |
| NCT00083538 | Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00243412 | A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00613626 | Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00144989 | A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01984073 | Effects of Niacin On Fatty Acid Trapping | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00005964 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | colorectal carcinoma | Folic Acid (NPC147983);Ascorbate (NPC187770) | NP level |
| NCT00202800 | Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Etoposide (NPC185498) | NP level |
| NCT00072527 | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01107730 | Vitamin C for Prophylaxis of Post-operative Atrial Fibrillation in On-pump Cardiac Surgery Procedures | atrial fibrillation | Ascorbate (NPC187770) | NP level |
| NCT00027846 | Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT02776605 | Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00004467 | Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen | Acute hepatic failure | Acetylcysteine (NPC248970) | NP level |
| NCT00244946 | Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00806819 | Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
| NCT03082001 | Sucrose to Reduce Pain During Initiation of Venipuncture in Extremely Low Birth Weight Babies | pain | Sucrose (NPC130683) | NP level |
| NCT04792021 | Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients | COVID-19 | Acetylcysteine (NPC248970) | NP level |
| NCT02949895 | Study of BMS-986012 in Subjects With Small Cell Lung Caner | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03663166 | Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04446104 | A Preventive Treatment for Migrant Workers at High-risk of COVID-19 | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT02142049 | Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01840345 | The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain | neuropathic pain | Acetylcysteine (NPC248970) | NP level |
| NCT01476839 | Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03016871 | Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00912392 | Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00211653 | Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery | kidney failure | Acetylcysteine (NPC248970) | NP level |
| NCT00127218 | High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly | atherosclerosis | Niacin (NPC167400) | NP level |
| NCT02881086 | Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT03385096 | Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01220297 | Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT | Abnormality of blood and blood-forming tissues | Etoposide (NPC185498) | NP level |
| NCT00006734 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00061893 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | sarcoma | Etoposide (NPC185498) | NP level |
| NCT03293173 | Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00660504 | Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT02269540 | A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A) | major depressive disorder | Acetylcysteine (NPC248970) | NP level |
| NCT02362425 | Antioxidant Therapy in RYR1-Related Congenital Myopathy | neuromuscular disease | Acetylcysteine (NPC248970) | NP level |
| NCT01548573 | Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00506506 | Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT01027923 | IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00002649 | Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | Burkitts lymphoma;diffuse large B-cell lymphoma;follicular lymphoma | Etoposide (NPC185498) | NP level |
| NCT04395768 | International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT00002800 | Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome | neutropenia;leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT01561547 | Trial of Repeated Analgesia With Kangaroo Care | pain | Sucrose (NPC130683) | NP level |
| NCT03460808 | The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia | autoimmune thrombocytopenic purpura | Acetylcysteine (NPC248970) | NP level |
| NCT00483314 | Homocystinuria: Treatment With N-Acetylcysteine | homocystinuria | Acetylcysteine (NPC248970) | NP level |
| NCT03391856 | Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy | Thrombocytopenia | Acetylcysteine (NPC248970) | NP level |
| NCT00078988 | High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT00152893 | To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities | HIV infection | Niacin (NPC167400) | NP level |
| NCT00004054 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT01850680 | Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT02179528 | Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04005716 | Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00000152 | Randomized Trial of Beta-Carotene and Macular Degeneration | macular degeneration | Beta Carotene (NPC17810) | NP level |
| NCT00463749 | Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein | myocardial infarction | Acetylcysteine (NPC248970) | NP level |
| NCT00045162 | S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01550510 | Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | colorectal adenocarcinoma | Ascorbate (NPC187770) | NP level |
| NCT00193505 | Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00049439 | Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006363 | Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | acute basophilic leukemia;acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00618995 | A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
| NCT00652431 | Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
| NCT00003632 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03908333 | High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Ascorbate (NPC187770) | NP level |
| NCT02870543 | Efficacy of Phytolacca Decandra and Melissa Officinalis in Children With Nocturnal Bruxism | Nocturnal Bruxism | Phytolacca Americana | Plant level As single plant |
| NCT05378919 | Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer | rectum cancer | Folic Acid (NPC147983) | NP level |
| NCT01555489 | Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
| NCT00576979 | Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT01183065 | Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) | head and neck malignant neoplasia | Folic Acid (NPC147983) | NP level |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | colorectal carcinoma | Pyridoxine (NPC269919) | NP level |
| NCT02686346 | Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00787059 | AC6 Gene Transfer for CHF | congestive heart failure | Sucrose (NPC130683) | NP level |
| NCT02574728 | Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT02116959 | Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT02605421 | Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00469209 | Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT01295450 | Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex | Anorexia | Ascorbate (NPC187770) | NP level |
| NCT00003243 | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer | myelodysplastic/myeloproliferative disease;leukemia;lymphoma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00020709 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | lung adenocarcinoma;squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05384821 | Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) | Wilms tumor | Etoposide (NPC185498) | NP level |
| NCT00255723 | Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT03992911 | Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
| NCT00146120 | Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00598169 | Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003575 | Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02371161 | Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03229616 | BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00936936 | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | testicular carcinoma | Etoposide (NPC185498) | NP level |
| NCT02243436 | Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT01070810 | Thiamine as a Metabolic Resuscitator in Septic Shock | septic shock | Thiamine (NPC150950) | NP level |
| NCT00004900 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00079040 | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03116971 | Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02063022 | Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma | Ewing sarcoma | Etoposide (NPC185498) | NP level |
| NCT03407144 | Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT03828929 | Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock | septic shock | Ascorbate (NPC187770) | NP level |
| NCT01134341 | Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma | anaplastic large cell lymphoma;mycosis fungoides;Sezary's disease | Folic Acid (NPC147983) | NP level |
| NCT00536237 | MK0524A Phase IIb Study (0524A-011)(COMPLETED) | Flushing | Niacin (NPC167400) | NP level |
| NCT00693719 | Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00143702 | D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE) | lactic acidosis | Thiamine (NPC150950) | NP level |
| NCT00002596 | Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors | childhood germ cell tumor;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT03356483 | Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. | obsessive-compulsive disorder | Niacin (NPC167400) | NP level |
| NCT00269217 | Lipid Efficacy Study (0524B-022)(COMPLETED) | Combined hyperlipidemia;Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT02775734 | NAC in CC Resistant PCOS After LOD | polycystic ovary syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT03104725 | Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? | Parkinson disease | Acetylcysteine (NPC248970) | NP level |
| NCT04328961 | Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT00002982 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00365755 | Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03154580 | Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users | cannabis dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00070187 | Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00265889 | Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00536978 | Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT02471911 | KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00808899 | Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00041054 | Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002588 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03649633 | Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock | septic shock | Ascorbate (NPC187770) | NP level |
| NCT01525927 | Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity | neoplasm of oropharynx | Etoposide (NPC185498) | NP level |
| NCT00018954 | Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
| NCT01104025 | Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
| NCT00071266 | The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC | intermittent vascular claudication | Niacin (NPC167400) | NP level |
| NCT03730064 | Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression | depressive disorder;bipolar disorder | Acetylcysteine (NPC248970) | NP level |
| NCT03926624 | Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02678234 | An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu | respiratory tract infectious disorder | Ascorbate (NPC187770) | NP level |
| NCT02429700 | TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors | ovarian sex cord-stromal tumor | Etoposide (NPC185498) | NP level |
| NCT03964688 | Effect of Vitamin C in Autologous Stem Cell Transplantations | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT05501548 | Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer | prostate cancer | Ascorbate (NPC187770) | NP level |
| NCT02703272 | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00481832 | Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00005578 | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02707640 | A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) | idiopathic pulmonary fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT01197560 | Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00430118 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT04683198 | Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04715022 | Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study) | hypertension | Ascorbate (NPC187770) | NP level |
| NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT03423667 | Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction | cocaine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT02293902 | A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT03149107 | "Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients" | schizophrenia | Acetylcysteine (NPC248970) | NP level |
| NCT00096330 | Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer | colorectal carcinoma | Folic Acid (NPC147983) | NP level |
| NCT01555970 | Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder | obsessive-compulsive disorder | Acetylcysteine (NPC248970) | NP level |
| NCT00278252 | Etoposide in Treating Young Patients With Relapsed Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00195871 | Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
| NCT05029037 | High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial. | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT00002816 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03004287 | 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00136084 | Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT05070650 | Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold | common cold | Acetylcysteine (NPC248970) | NP level |
| NCT00004010 | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00004188 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT00053352 | Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors | Ovarian Embryonal Carcinoma;Ovarian Yolk Sac Tumor;teratoma;Testicular Choriocarcinoma;Testicular Yolk Sac Tumor | Etoposide (NPC185498) | NP level |
| NCT01439828 | Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal | cannabis dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00723658 | S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00499018 | Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00703196 | Folic Acid Clinical Trial for the Prevention of Cervical Cancer | cervical cancer | Folic Acid (NPC147983) | NP level |
| NCT00025636 | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01555541 | Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00962442 | N-Acetylcysteine in Severe Acute Alcoholic Hepatitis | Hepatitis, Alcoholic | Acetylcysteine (NPC248970) | NP level |
| NCT00954525 | Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
| NCT02512926 | Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children | leukemia | Etoposide (NPC185498) | NP level |
| NCT00801918 | Denileukine Diftitox for Relapsed ALCL | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00205647 | Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis | chronic bronchitis | Acetylcysteine (NPC248970) | NP level |
| NCT04982146 | Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei | pseudomyxoma peritonei | Acetylcysteine (NPC248970) | NP level |
| NCT05192889 | Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00736866 | The Acetylcysteine for Contrast-Induced Nephropathy Trial | acute kidney failure | Acetylcysteine (NPC248970) | NP level |
| NCT00186849 | Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT00003093 | Combination Chemotherapy in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04585893 | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi | Castleman disease | Etoposide (NPC185498) | NP level |
| NCT00410423 | Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias | leukemia | Etoposide (NPC185498) | NP level |
| NCT00354107 | Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma | anaplastic large cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002715 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04203511 | INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00539513 | N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder | obsessive-compulsive disorder | Acetylcysteine (NPC248970) | NP level |
| NCT04044222 | A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT04677049 | Study of Niacin in Glioblastoma | glioblastoma multiforme | Niacin (NPC167400) | NP level |
| NCT00500890 | Treatment of Tumors of the Choroid Plexus Epithelium | choroid plexus neoplasm | Etoposide (NPC185498) | NP level |
| NCT01947062 | Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma | squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00574080 | UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00335738 | Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT02182167 | A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis | drug-induced hepatitis | Acetylcysteine (NPC248970) | NP level |
| NCT02930343 | Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00871013 | Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT02369822 | Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy | epilepsy | Ascorbate (NPC187770) | NP level |
| NCT00083915 | DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00025324 | Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00387699 | Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03669783 | Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm) | childhood kidney neoplasm | Etoposide (NPC185498) | NP level |
| NCT02199184 | Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia | AIDS;acute lymphoblastic leukemia;Burkitts lymphoma | Etoposide (NPC185498) | NP level |
| NCT03334409 | Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery | clear cell renal carcinoma | Ascorbate (NPC187770) | NP level |
| NCT00003727 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | colorectal carcinoma | Pyridoxine (NPC269919) | NP level |
| NCT05001412 | Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00542750 | An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents | cannabis dependence | Acetylcysteine (NPC248970) | NP level |
| NCT03509662 | Vitamin C in Post-cardiac Arrest | cardiac arrest | Ascorbate (NPC187770);Thiamine (NPC150950) | NP level |
| NCT00134030 | Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
| NCT02018965 | Niacin on Immune Activation : a Proof-of-concept Study | HIV infection | Niacin (NPC167400) | NP level |
| NCT03367143 | Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00764907 | Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02964013 | Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) | neoplasm | Etoposide (NPC185498) | NP level |
| NCT01439568 | A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01131468 | Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine | hearing loss | Acetylcysteine (NPC248970) | NP level |
| NCT00030719 | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01569204 | Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00397917 | Oral Cleft Prevention Program | cleft lip;Cleft palate | Folic Acid (NPC147983) | NP level |
| NCT04916080 | N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT02086864 | A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD | attention deficit hyperactivity disorder | Sucrose (NPC130683) | NP level |
| NCT02541045 | Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis | non-alcoholic fatty liver disease | Pyridoxine (NPC269919) | NP level |
| NCT02570542 | Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01458366 | Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT01511562 | Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04374461 | A Study of N-acetylcysteine in Patients With COVID-19 Infection | COVID-19 | Acetylcysteine (NPC248970) | NP level |
| NCT01569919 | A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma | mesothelioma | Folic Acid (NPC147983) | NP level |
| NCT00634998 | Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy | diabetic neuropathy | Ascorbate (NPC187770) | NP level |
| NCT00179920 | Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT01221402 | Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis | atherosclerosis | Niacin (NPC167400) | NP level |
| NCT00006669 | Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00275015 | Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia | chronic lymphocytic leukemia | Etoposide (NPC185498) | NP level |
| NCT01565772 | Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05403723 | Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00003299 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01169636 | Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT02937116 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
| NCT00006021 | Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT02786823 | Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Folic Acid (NPC147983) | NP level |
| NCT03591510 | A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00627705 | A Study of N-Acetyl Cysteine in Children With Autism | autism | Acetylcysteine (NPC248970) | NP level |
| NCT03383406 | A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01033149 | N-acetylcysteine in the Treatment of Bulimia Nervosa | bulimia nervosa | Acetylcysteine (NPC248970) | NP level |
| NCT04372927 | ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01165112 | Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma | diffuse large B-cell lymphoma;Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT05458180 | CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00578864 | Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00025103 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT00953134 | Periconceptional Iron Supplementation in Rural Bangladesh | anemia (phenotype) | Folic Acid (NPC147983) | NP level |
| NCT00869752 | MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00003935 | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | brain neoplasm | Etoposide (NPC185498) | NP level |
| NCT01710176 | Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
| NCT01025778 | Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00266227 | A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00002674 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00653068 | Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System | neoplasm | Etoposide (NPC185498) | NP level |
| NCT04728230 | Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00529503 | A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003052 | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT03882177 | StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis | pulmonary tuberculosis | Pyridoxine (NPC269919) | NP level |
| NCT00577993 | Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002566 | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT02400281 | Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT01010581 | SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00551005 | Etoposide and Celecoxib in Patients With Advanced Cancer | neoplasm | Etoposide (NPC185498) | NP level |
| NCT01983969 | Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma | cancer;lymphoma | Pyridoxine (NPC269919) | NP level |
| NCT02093026 | Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT03410030 | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | pancreatic ductal adenocarcinoma | Ascorbate (NPC187770) | NP level |
| NCT00887159 | A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03298074 | Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00002522 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04631536 | Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC | COVID-19 | Folic Acid (NPC147983) | NP level |
| NCT00006260 | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT00632853 | Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00350181 | Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT | acute graft vs. host disease;leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002510 | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04703036 | Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19 | COVID-19 | Acetylcysteine (NPC248970) | NP level |
| NCT01000285 | EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma | T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03643276 | Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT03346681 | N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome | acute respiratory distress syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT00003941 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | mediastinal cancer;testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT00000555 | Women's Angiographic Vitamin and Estrogen Trial (WAVE) | menopause;Myocardial Ischemia | Ascorbate (NPC187770) | NP level |
| NCT03541486 | A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients | pancreatic neoplasm | Ascorbate (NPC187770) | NP level |
| NCT03602235 | High Dose Ascorbic Acid for Plasma Cell Disorders | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT00003783 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00775476 | Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine | systemic lupus erythematosus | Acetylcysteine (NPC248970) | NP level |
| NCT00948090 | PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00006455 | Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02660762 | Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL | leukemia | Etoposide (NPC185498) | NP level |
| NCT00939653 | T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00021112 | Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00369317 | Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes | acute basophilic leukemia;acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT01082445 | Effects of N-acetylcysteine on Diabetic Foot Oxygenation | diabetic foot | Acetylcysteine (NPC248970) | NP level |
| NCT00209222 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04452370 | Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
| NCT01381354 | Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) | multiple sclerosis | Acetylcysteine (NPC248970) | NP level |
| NCT02366663 | BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00300352 | Effect of Folic Acid Treatment in Coronary Artery Disease | coronary artery disease | Folic Acid (NPC147983) | NP level |
| NCT02168270 | Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma | anaplastic astrocytoma;anaplastic oligodendroglioma;gliosarcoma | Ascorbate (NPC187770) | NP level |
| NCT00678327 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00002829 | Bone Marrow Transplantation in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00124644 | Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00002611 | Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | kidney cancer | Etoposide (NPC185498) | NP level |
| NCT01214083 | N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence | alcohol dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00973882 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT01054508 | Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers | Hypercholesterolemia | Niacin (NPC167400) | NP level |
| NCT02521077 | Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer | Fatigue | Ascorbate (NPC187770) | NP level |
| NCT05367856 | Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00088530 | BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00000599 | Cholesterol-Lowering Atherosclerosis Study (CLAS) | carotid artery disease;cerebral atherosclerosis;Myocardial Ischemia | Niacin (NPC167400) | NP level |
| NCT02025881 | Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma | medulloblastoma | Etoposide (NPC185498) | NP level |
| NCT03467360 | Inhibition of CArbonic Anhydrase in Combination With Platinum and Etoposide-based Radiochemotherapy in Patients With Localized Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01555710 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00000660 | Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | Kaposi's sarcoma | Etoposide (NPC185498) | NP level |
| NCT00045617 | S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04481035 | Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1 | neurofibromatosis type 1 | Acetylcysteine (NPC248970) | NP level |
| NCT00154700 | Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer | esophageal cancer | Folic Acid (NPC147983) | NP level |
| NCT03224572 | The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients | ascorbic acid deficiency | Ascorbate (NPC187770) | NP level |
| NCT01063205 | NAC as a Potential Treatment for Methamphetamine Dependence | substance abuse;methamphetamine dependence | Acetylcysteine (NPC248970) | NP level |
| NCT03956888 | The Anti-oxidant Effects of N-Acetylcysteine in Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Acetylcysteine (NPC248970) | NP level |
| NCT00003084 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
| NCT04063163 | A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03937843 | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma | seminoma;testicular carcinoma | Etoposide (NPC185498) | NP level |
| NCT01808521 | A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura | thrombotic thrombocytopenic purpura;autoimmune thrombocytopenic purpura | Acetylcysteine (NPC248970) | NP level |
| NCT00062556 | Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication | intermittent vascular claudication | Niacin (NPC167400) | NP level |
| NCT04917250 | GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00458848 | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT02504671 | Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00002941 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00519207 | Evaluation of Topical Liposomal Lidocaine and Oral Sucrose for Treatment of Pain in Newborns Undergoing Venipuncture | pain | Sucrose (NPC130683) | NP level |
| NCT04918719 | Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke | Ischemic stroke | Acetylcysteine (NPC248970) | NP level |
| NCT03531281 | Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT00110110 | Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT03043872 | Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00304018 | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer | leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00258245 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT01237678 | A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04279535 | Topical Vitamin C for Treatment of Basal Cell Cancer | basal cell carcinoma | Ascorbate (NPC187770) | NP level |
| NCT00151255 | All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02763579 | A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02083575 | Role of Vitamin C to Augment Iron Chelation With DFP or DFX | beta-thalassemia major | Ascorbate (NPC187770) | NP level |
| NCT01015209 | Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers | dry eye syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT03055377 | N-Acetylcysteine for Youth Cannabis Use Disorder | cannabis dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00242996 | Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00441870 | Study of EC0225 for the Treatment of Refractory or Metastatic Tumors | cancer | Folic Acid (NPC147983) | NP level |
| NCT03516903 | Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI | myocardial infarction | Folic Acid (NPC147983) | NP level |
| NCT00284427 | Safety of Antioxidants During GYN Cancer Care | cervical cancer;ovarian cancer | Ascorbate (NPC187770) | NP level |
| NCT02349178 | Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT05422183 | Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00202280 | Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication | psychosis | Folic Acid (NPC147983);Pyridoxine (NPC269919) | NP level |
| NCT01949116 | Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications | HIV infection | Folic Acid (NPC147983) | NP level |
| NCT00776802 | GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02323737 | Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00220532 | Folate and Protection Against Cervical Cancer | cervical cancer | Folic Acid (NPC147983) | NP level |
| NCT04864496 | Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa | retinitis pigmentosa | Acetylcysteine (NPC248970) | NP level |
| NCT01423747 | Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00231582 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | testicular neoplasm | Etoposide (NPC185498) | NP level |
| NCT04681417 | Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome | retinoblastoma | Etoposide (NPC185498) | NP level |
| NCT02631252 | Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02819999 | A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00400946 | Treatment of Acute Lymphoblastic Leukemia in Children | leukemia | Etoposide (NPC185498) | NP level |
| NCT02538926 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | T-lymphoblastic lymphoma;T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00703820 | Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04177004 | Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT01729845 | Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT00961636 | A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00417248 | Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01703104 | The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia | sickle cell anemia | Folic Acid (NPC147983) | NP level |
| NCT02833350 | Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00002701 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT00441207 | Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors | cancer | Ascorbate (NPC187770) | NP level |
| NCT00876031 | Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
| NCT00002634 | Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT02733107 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT01411098 | Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00118209 | Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003541 | Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04696939 | Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04774380 | Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04801511 | Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer | rectum cancer | Ascorbate (NPC187770) | NP level |
| NCT01356966 | Exercise Intolerance in Renal Failure | chronic kidney disease | Folic Acid (NPC147983) | NP level |
| NCT00689169 | Targeted Intensification With ZBEAM and Autologous Stem Cell Transplantation in Patients With High-grade B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03188445 | Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy. | Iron deficiency anemia | Ascorbate (NPC187770) | NP level |
| NCT03840902 | M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00613223 | Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas | gliosarcoma | Etoposide (NPC185498) | NP level |
| NCT00354744 | High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | sarcoma | Etoposide (NPC185498) | NP level |
| NCT00396500 | Deworming and Vitamin A (DEVTA) Prepilot Study | malnutrition;parasitic infection | Retinol (NPC55412) | NP level |
| NCT01411267 | AC220 for Children With Relapsed/Refractory ALL or AML | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT02088502 | Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy | kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT04469530 | Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
| NCT03711305 | Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00882076 | Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias | leukemia | Etoposide (NPC185498) | NP level |
| NCT01959698 | Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT00079482 | Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT00003812 | Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00085345 | Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT00003816 | Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer | chronic myeloproliferative disorder;leukemia;lymphoma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
| NCT01720095 | Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis | psychosis | Niacin (NPC167400) | NP level |
| NCT00051311 | Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT00482053 | Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04260516 | The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major | beta-thalassemia major | Acetylcysteine (NPC248970) | NP level |
| NCT01579929 | Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | lung cancer | Etoposide (NPC185498) | NP level |
| NCT01704482 | N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement | kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00002740 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04660097 | Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00065455 | Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa | retinitis pigmentosa | Retinol (NPC55412) | NP level |
| NCT00533611 | Effect of MK0524A on Flushing Caused by Niacin (0524A-056) | Flushing | Niacin (NPC167400) | NP level |
| NCT03072771 | Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04123405 | Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis | sinusitis | Acetylcysteine (NPC248970) | NP level |
| NCT03583710 | Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
| NCT03509350 | Vitamin C, Thiamine, and Steroids in Sepsis | Sepsis | Ascorbate (NPC187770);Thiamine (NPC150950) | NP level |
| NCT03850067 | A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00275418 | Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease | Crohn's disease | Beta Carotene (NPC17810) | NP level |
| NCT00985855 | Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00944645 | MK0524A Bioequivalence Study (0524A-059) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT03077828 | Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
| NCT00310128 | Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma | anaplastic large cell lymphoma;Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT00793845 | Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03273829 | Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children | leukemia | Etoposide (NPC185498) | NP level |
| NCT00807807 | Evaluating the Effects of Folic Acid Supplementation in Older Adults: The Folic Acid Supplementation Trial (The FAST Study) | heart disease | Folic Acid (NPC147983) | NP level |
| NCT00301587 | A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives | neural tube defect | Folic Acid (NPC147983) | NP level |
| NCT01005810 | A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana | cannabis dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00060385 | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00003578 | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT00807755 | Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors | lung cancer | Etoposide (NPC185498) | NP level |
| NCT03800667 | Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries | urinary tract infection | Ascorbate (NPC187770) | NP level |
| NCT03752918 | The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. | post-traumatic stress disorder | Niacin (NPC167400) | NP level |
| NCT02562365 | Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00428883 | High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis | diffuse scleroderma | Acetylcysteine (NPC248970) | NP level |
| NCT00977561 | A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00098319 | Oral Cleft Prevention Trial in Brazil | cleft lip;Cleft palate | Folic Acid (NPC147983) | NP level |
| NCT02730949 | D-chiro-Inositol in Overweight Type 1 Diabetes Patients | type 1 diabetes mellitus | Folic Acid (NPC147983) | NP level |
| NCT02782754 | Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma | germ cell tumor | Etoposide (NPC185498) | NP level |
| NCT05452772 | 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder | nicotine dependence | Niacin (NPC167400) | NP level |
| NCT00453180 | A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders | Asperger syndrome;autism | Acetylcysteine (NPC248970) | NP level |
| NCT00278278 | Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT01050621 | Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective | cancer | Ascorbate (NPC187770) | NP level |
| NCT00476190 | ALL Adult Consortium Trial: Adult ALL Trial | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT02228512 | Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | Castleman disease;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT05124951 | The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors | central nervous system cancer | Etoposide (NPC185498) | NP level |
| NCT00499343 | G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02592876 | Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma | Etoposide (NPC185498) | NP level |
| NCT03041311 | Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00066742 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00017225 | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04363255 | First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00020943 | Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01319734 | Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Ascorbate (NPC187770) | NP level |
| NCT00289900 | Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) | Combined hyperlipidemia | Niacin (NPC167400) | NP level |
| NCT00950989 | Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT05338541 | Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood. | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT04855266 | Iron Sucrose in Patients With Iron Deficiency and POTS | orthostatic hypotension | Sucrose (NPC130683) | NP level |
| NCT01711359 | A Study in Participants With Moderate to Severe Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
| NCT00056225 | VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study) | Alzheimer disease | Folic Acid (NPC147983);Pyridoxine (NPC269919) | NP level |
| NCT01958372 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | lung adenocarcinoma | Etoposide (NPC185498) | NP level |
| NCT00225173 | Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
| NCT00480207 | Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults | depressive disorder | Folic Acid (NPC147983) | NP level |
| NCT02265770 | An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma | childhood ependymoma | Etoposide (NPC185498) | NP level |
| NCT00003114 | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04139304 | A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT03699956 | RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT00983944 | Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT02730364 | An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu | respiratory tract infectious disorder | Ascorbate (NPC187770) | NP level |
| NCT02338518 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients | gastric cancer | Etoposide (NPC185498) | NP level |
| NCT04833114 | Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT01251029 | Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia | chronic kidney disease | Acetylcysteine (NPC248970) | NP level |
| NCT00957359 | Psilocybin Cancer Anxiety Study | cancer | Niacin (NPC167400) | NP level |
| NCT02638428 | Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04300920 | Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial | idiopathic pulmonary fibrosis | Acetylcysteine (NPC248970) | NP level |
| NCT00025428 | Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
| NCT03697239 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Ascorbate (NPC187770) | NP level |
| NCT00002704 | Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03680274 | Lessening Organ Dysfunction With VITamin C | COVID-19;Sepsis | Ascorbate (NPC187770) | NP level |
| NCT03306979 | Memory and Antioxidants in Vascular Impairment Trial | Cognitive impairment | Acetylcysteine (NPC248970) | NP level |
| NCT00388960 | Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT03811002 | Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
| NCT04334512 | A Study of Quintuple Therapy to Treat COVID-19 Infection | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT04354428 | Treatment for COVID-19 in High-Risk Adult Outpatients | COVID-19 | Folic Acid (NPC147983);Ascorbate (NPC187770) | NP level |
| NCT00227682 | Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT03018626 | R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT04482686 | Trial of Combination Therapy to Treat COVID-19 Infection | COVID-19;severe acute respiratory syndrome | Ascorbate (NPC187770) | NP level |
| NCT01785186 | Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design | tuberculosis | Pyridoxine (NPC269919) | NP level |
| NCT02905591 | A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
| NCT01436266 | Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion | hemorrhage | Folic Acid (NPC147983) | NP level |
| NCT00002868 | Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT03493178 | Glutathione in Mild Cognitive Impairment | Cognitive impairment | Acetylcysteine (NPC248970) | NP level |
| NCT02421939 | A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
| NCT03238300 | Neuroscience-Informed Treatment Development for Adolescent Alcohol Use | alcohol drinking | Acetylcysteine (NPC248970) | NP level |
| NCT05348213 | Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
| NCT02911142 | Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma | B-cell neoplasm | Etoposide (NPC185498) | NP level |
| NCT02947750 | Neurovascular Transduction During Exercise in Chronic Kidney Disease | chronic kidney disease | Folic Acid (NPC147983) | NP level |
| NCT00002638 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
| NCT04989049 | Therapeutic Effect of Folic Acid in Healing of Oral Ulcers | Oral ulcer | Folic Acid (NPC147983) | NP level |
| NCT04964843 | A Study of NAC for AUD | alcohol dependence | Acetylcysteine (NPC248970) | NP level |
| NCT00042835 | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | lung adenocarcinoma;squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01900431 | Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis | uveitis | Folic Acid (NPC147983) | NP level |
| NCT02541708 | IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania | Iron deficiency anemia | Folic Acid (NPC147983) | NP level |
| NCT00265031 | HD12 for Advanced Stages | lymphoma | Etoposide (NPC185498) | NP level |
| NCT04545008 | Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19 | COVID-19 | Acetylcysteine (NPC248970) | NP level |
| NCT03718507 | Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants | acute respiratory distress syndrome | Sucrose (NPC130683) | NP level |
| NCT02833701 | Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
| NCT02101853 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Etoposide (NPC185498) | NP level |
| NCT00170404 | TB Nutrition, Immunology and Epidemiology | tuberculosis | Niacin (NPC167400);Retinol (NPC55412);Folic Acid (NPC147983) | NP level |
| NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
| NCT01071291 | Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
| NCT00066222 | Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
| NCT00112879 | Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
| NCT00003996 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
| NCT00320359 | Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04987775 | GWICTIC: NAC Mechanistic Study in Gulf War Veterans | persian gulf syndrome | Acetylcysteine (NPC248970) | NP level |
| NCT00042978 | Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT04000295 | Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
| NCT00094497 | Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | carcinoma | Etoposide (NPC185498) | NP level |
| NCT02186158 | Interest of Ascorbic Acid in the Management of Pneumonia in Elderly People Hospitalized. | pneumonia | Ascorbate (NPC187770) | NP level |
| NCT00003399 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
| NCT00621361 | Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients | lung cancer | Etoposide (NPC185498) | NP level |
| NCT04401150 | Lessening Organ Dysfunction With VITamin C - COVID-19 | COVID-19 | Ascorbate (NPC187770) | NP level |
| NCT02883049 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
| NCT04380636 | Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT01953536 | Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) | breast neoplasm | Folic Acid (NPC147983) | NP level |
| NCT00354770 | N-Acetyl Cysteine in Trichotillomania | Hair-pulling | Acetylcysteine (NPC248970) | NP level |
| NCT00006461 | Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor | medulloblastoma;primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
| NCT01822496 | Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
| NCT02784015 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
| NCT02589145 | Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype | lymphoma | Pyridoxine (NPC269919) | NP level |
❱❱❱ Associated Human Diseases and Detailed Association Evidence
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
|---|---|
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT02356159,NCT00005863,NCT02385110,NCT00002531,NCT00002567,NCT00304018,NCT00002800,NCT00576979,NCT00025402,NCT00003243,NCT00003727,NCT00534469,NCT01900509,NCT00040690,NCT02660762,NCT00536978,NCT00002768,NCT00002701,NCT00274807,NCT00410423,NCT00002925,NCT00002766,NCT00002757,NCT00004086,NCT00005977,NCT00018954,NCT00002756,NCT00002517,NCT00100477,NCT00109031,NCT00124644,NCT00002945,NCT02512926,NCT03273829,NCT01117441,NCT00002549,NCT00003816,NCT00006040,NCT00002926,NCT00002532,NCT00003402,NCT00004905,NCT00618501,NCT00039130,NCT00002865,NCT00002494,NCT00005802,NCT00458848,NCT00002674,NCT00004898,NCT00008190,NCT00764907,NCT00002588,NCT00002471,NCT00630565,NCT00006045,NCT00070174,NCT00006122,NCT00002961,NCT00002658,NCT00350181,NCT00004128,NCT00003783,NCT00005946,NCT00613457,NCT00052299,NCT00400946,NCT00002816,NCT00882076,NCT00002688,NCT01154439,NCT00002912,NCT00002788,NCT00427791,NCT00002719,NCT00002598,NCT00004904,NCT00002704,NCT00002514,NCT00003602,NCT00002868,NCT00430118,NCT00002638,NCT00003728,NCT00005823,NCT00002805,NCT00005793,NCT00002785,NCT00372593,NCT00003436
|
Peripheral T-cell lymphoma, not otherwise specifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.C |
NCT00632827,NCT02106650,NCT00970385,NCT02013362,NCT03321890,NCT04061772,NCT03586999,NCT05458180,NCT00791947
|
Burkitt lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KA9 |
NCT05270057,NCT00057811,NCT05389423,NCT02199184,NCT00126191,NCT00002649,NCT01092182,NCT00058461,NCT00073918
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
TOP2B
NCT01300793,NCT00054665,NCT02443077,NCT00968760,NCT03206671,NCT00324467,NCT02405676 |
Primary neoplasms of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
NCT00003573,NCT00003625,NCT00085098,NCT00027846,NCT02905110,NCT00078988,NCT00003141,NCT00003935
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT00193531,NCT05076786,NCT03992911,NCT00003558,NCT03168594,NCT00001339,NCT05142865,NCT00094497
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
NCT00672360,NCT00325572,NCT00627705,NCT05494398,NCT04278898,NCT00453180,NCT03008889,NCT00676195
|
Primary haemophagocytic lymphohistiocytosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01.23 |
NCT01818908,NCT03742115,NCT02912702,NCT04551131,NCT04077905,NCT01104025,NCT02631109,NCT00426101
|
Classical Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30.1 |
NCT05008224,NCT02243436,NCT00967369,NCT02661503,NCT02166463,NCT03077828,NCT00025259,NCT04044222
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
HCAR2,TSHR,GLO1,CASP3,GSTP1,AKR1B10,ALOX15,FFAR1
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
ACHE,F3,ADRA2B,FFAR1
NCT00054938,NCT00470522,NCT00775476 |
AnemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A00-3A9Z |
NCT01490944,NCT00920413,NCT02780505,NCT00953134,NCT01670955,NCT02225886,NCT02631668
|
HyperlipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
NCT00536510,NCT00384293,NCT01583647,NCT00652431,NCT00378833,NCT00376584,NCT00203476
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000599,NCT00000482,NCT00000541,NCT00000512,NCT00000553,NCT00000461,NCT00000555
|
Septic shockDisease Category: X.Extension CodesDisease ICD-11 Code: XS26 |
NCT03649633,NCT03592693,NCT03828929,NCT03872011,NCT04999137,NCT03333278,NCT01070810
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT02344355,NCT01752491,NCT04677049,NCT04900792,NCT04765098,NCT02372409,NCT02833701
|
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
NCT03423667,NCT02141620,NCT02994875,NCT00218491,NCT03556371,NCT04155632,NCT00136825
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
ACHE,ALOX5,AKR1B10,PTPRC,TSHR,ALOX5
NCT04322318 |
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
LMNA,BLM,HCAR2,TSHR,CASP3,AKR1B10,PTPRC
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
MAPK1,GSTP1,APP,ALOX5,TOP2B,F3
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
APP,TOP2B,ACHE,SNCA
NCT00056225,NCT04740580 |
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
TOP2B
NCT00170404,NCT01936831,NCT01785186,NCT02563327,NCT03702738 |
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
TOP2B
NCT00086944,NCT03019640,NCT02592876,NCT00002649,NCT00073918 |
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT01221402,NCT00114400,NCT00120289,NCT00397657,NCT00127218,NCT00150722
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT00042835,NCT03908333,NCT03410030,NCT00020709,NCT03697239,NCT01958372
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NCT04999137,NCT02734147,NCT03509350,NCT03333278,NCT01590303,NCT03680274
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT03797443,NCT00954525,NCT01905150,NCT01555489,NCT01364805,NCT00202800
|
GerminomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1E13 |
NCT00864318,NCT00002596,NCT02582697,NCT01873326,NCT00274950,NCT02782754
|
Anaplastic large cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1LC0 |
NCT01134341,NCT00057811,NCT01979536,NCT00073918,NCT00310128,NCT00354107
|
Cannabis use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C41 |
NCT01005810,NCT00542750,NCT01439828,NCT03154580,NCT03055377,NCT01675661
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT01775475,NCT00049036,NCT00002571,NCT00001563,NCT00002524,NCT00310128
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
NCT00180908,NCT00504140,NCT01258634,NCT04154189,NCT00134030,NCT00023998
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
NCT04300920,NCT02707640,NCT04312594,NCT00650091,NCT03720483,NCT00639496
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
ACHE,HCAR2,AKR1B10,ALOX15,PTPRC
NCT02633514 |
Alcohol dependenceDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40.2 |
NCT03216954,NCT03120468,NCT00568087,NCT01214083,NCT03707951,NCT04964843
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
CDC25B,ALOX5,GSTP1,TOP2B
NCT00660504,NCT00402883,NCT00002887,NCT03567642,NCT00033722,NCT00041015,NCT00021112,NCT00869752,NCT00807755,NCT00002550,NCT00003053,NCT00003606,NCT00003812,NCT00003299,NCT00002822,NCT00984997,NCT01134861,NCT00554463,NCT00045617,NCT00005022,NCT00062439,NCT00011921,NCT01579929,NCT00006374,NCT00589056,NCT00004186,NCT00002823,NCT00003860,NCT00144989,NCT00072527,NCT00002642,NCT00083161,NCT00003583,NCT00061919,NCT03432598,NCT00621361,NCT00066222,NCT00033696,NCT00045162,NCT00002858,NCT00632853,NCT00003696,NCT00003284,NCT00003158,NCT00041054,NCT00049218,NCT00006012,NCT00025272,NCT03811002,NCT00726986,NCT00616785,NCT00003364,NCT00387699,NCT00004176,NCT00006487 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
PTPRC,TOP2B
NCT04293562,NCT03793478,NCT03164057,NCT00703820,NCT00184054,NCT03839446,NCT02349178,NCT01729845,NCT00906945,NCT02631252,NCT02306291,NCT00329498,NCT02400281,NCT01025778,NCT00146120,NCT03860844,NCT03926624,NCT01180322,NCT03182244,NCT02070458,NCT00780104,NCT00079482,NCT00660036,NCT00315705,NCT02626338,NCT02773732,NCT02638428,NCT02039726,NCT01411267,NCT00186966,NCT02632708,NCT02848183,NCT01677949,NCT00006363,NCT01681537,NCT01237808,NCT01830777,NCT00003190,NCT03118466,NCT01027923,NCT00136084,NCT00512252,NCT00151255,NCT03591510,NCT02421939,NCT00880243,NCT03504410,NCT04326439,NCT00369317,NCT00003190,NCT03568994,NCT00939653,NCT00151242,NCT00002798,NCT00774046 |
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TOP2B,PTPRC
NCT03018626,NCT05389423,NCT03229616,NCT00591630,NCT01226849,NCT00057811,NCT00776802,NCT04833114,NCT02329080,NCT00482053,NCT02412267,NCT01415765,NCT04139304,NCT01030900,NCT02219737,NCT03293173,NCT03736616,NCT03367143,NCT01555541,NCT01959698,NCT00137995,NCT05348213,NCT05364424,NCT03383406,NCT00058461,NCT02228512,NCT01481272,NCT00499018,NCT00529503,NCT01181271,NCT00556127,NCT02636322,NCT00002649,NCT01914718,NCT04002947,NCT01092182,NCT01165112,NCT03349346,NCT02592876,NCT02366663,NCT05221645,NCT02142049,NCT03072771,NCT00689169,NCT03064867,NCT02471911,NCT03213977,NCT01197560,NCT03019640,NCT00086944,NCT02570542,NCT05466318,NCT00073918 |
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
ACHE,SNCA
NCT01470027,NCT02212678,NCT03104725 |
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
TOP2B,PTPRC
NCT00051311,NCT04177004,NCT03531281 |
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
ALOX5
NCT00272610,NCT03391856,NCT05123365,NCT01014546 |
NADisease Category: NADisease ICD-11 Code: NA |
NCT00781196,NCT04553666,NCT00062556,NCT00071266,NCT00428883
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT00953212,NCT01580683,NCT03148236,NCT01107730,NCT02750319
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
NCT00000541,NCT03516903,NCT00120289,NCT00000482,NCT00463749
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT04301336,NCT01849016,NCT00508989,NCT01800526,NCT01703104
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
NCT05452772,NCT00067899,NCT02737358,NCT02723162,NCT00751257
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
NCT00995085,NCT01685281,NCT02189772,NCT01243242,NCT02086864
|
Neuropathy, ataxia, and retinitis pigmentosaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C73.1 |
NCT00000114,NCT00065455,NCT00000116,NCT04864496,NCT03063021
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
BLM,AKR1B10,GSTP1,NCOA3
NCT03017326 |
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
LMNA,BLM,ALOX5,GSTP1,F3
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
CDC25B,BLM,TSHR,PTPN1,AKR1B10
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
TSHR,BLM,ADRA2B,SLCO1B1,AKR1B10
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
ACHE,CDC25B,BLM,SLCO1B1,ALOX15
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
ACHE,BLM,TSHR,SLCO1B1,AKR1B10
|
Neuroblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH85Z0 |
NCT00276731,NCT00578864,NCT04221035,NCT00025623,NCT00030719,NCT02605421,NCT00070200,NCT00416676,NCT00005978,NCT05338541,NCT00253435,NCT00004188,NCT00024193,NCT00025649,NCT00025610,NCT03786783,NCT00798148,NCT00004110,NCT00002740,NCT00002634,NCT02771743,NCT00017225,NCT00186849,NCT00003093,NCT00040872,NCT03061656,NCT00793845,NCT00567567,NCT00365755,NCT01059071,NCT00499616,NCT00017368,NCT01704716,NCT00003141,NCT00025597,NCT00135135,NCT01857934,NCT00003119,NCT00025428,NCT00808899,NCT02176967,NCT00539500,NCT00002802
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT00869232,NCT00112879,NCT00572169,NCT02206425,NCT00258245,NCT02114502,NCT00006021,NCT00469209,NCT00317811,NCT00085345,NCT00005946,NCT00004904,NCT00349778,NCT03964688,NCT00227682,NCT01055301,NCT00083915,NCT00083538,NCT03602235,NCT00734877,NCT03385096,NCT00004903,NCT05294055,NCT00006184,NCT00661544,NCT00574080,NCT03004287,NCT02356159,NCT00002552,NCT03570983,NCT00005987,NCT00871013,NCT00083681,NCT00002657,NCT01548573,NCT00005834,NCT00003399,NCT00304018,NCT01653418,NCT02504359,NCT00003401,NCT00083551
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT02420314,NCT01194453,NCT01165021,NCT02768558,NCT00606502,NCT01076231,NCT00806819,NCT00609518,NCT02987998,NCT00216125,NCT02905591,NCT02655913,NCT01733589,NCT03944772,NCT03799094,NCT05096663,NCT00240097,NCT02733107,NCT05298423,NCT02947113,NCT03663166,NCT00682383,NCT01222572,NCT00776698,NCT01411098,NCT00985855,NCT01565772,NCT00417248,NCT04989283,NCT03519971,NCT04372927,NCT00924209,NCT04380636,NCT03840902,NCT00191139,NCT01993810,NCT02262325,NCT04092283,NCT00686959,NCT02940990,NCT04203511,NCT01822496
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT05453500,NCT01025778,NCT02003222,NCT05192889,NCT00137111,NCT02518750,NCT00186875,NCT03643276,NCT01423500,NCT02199184,NCT00187083,NCT01949129,NCT03991884,NCT01423747,NCT02881086,NCT01457040,NCT00187005,NCT03023046,NCT00098839,NCT02883049,NCT00022737,NCT02043587,NCT00187161,NCT01411267,NCT03117751,NCT00476190,NCT02553460,NCT03860844,NCT01331590,NCT00315705,NCT03020030,NCT02349178,NCT03553238,NCT01677949,NCT00549848,NCT00131027,NCT02776605,NCT00720109,NCT00057811,NCT02101853
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TOP2B,GSTP1,F3,MAPK1
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
F3
NCT04404387,NCT03346681,NCT03718507 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
TOP2B
NCT01381354,NCT05122559,NCT00203099 |
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT02773147,NCT00152893,NCT01949116,NCT02018965
|
GliosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9RC8 |
NCT02168270,NCT02502708,NCT00613223,NCT00612430
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT03149107,NCT00211562,NCT01506765,NCT01885338
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
NCT00406874,NCT01407432,NCT03241472,NCT02493933
|
Soft tissue disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB56 |
NCT03508726,NCT02784015,NCT01710176,NCT00876031
|
Iron deficiency anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A00 |
NCT03481790,NCT02541708,NCT04268849,NCT03188445
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
NCT04952051,NCT00520247,NCT04832009,NCT04715022
|
Acute megakaryoblastic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.36 |
NCT00002798,NCT00006363,NCT00369317,NCT00003190
|
Obsessive-compulsive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B20 |
NCT03356483,NCT00539513,NCT01555970,NCT01172275
|
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
NCT02318446,NCT02369822,NCT00004758,NCT05485558
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
NCT03015675,NCT02338518,NCT02949258 |
Acute monocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9NE2 |
NCT00006363,NCT00003190,NCT00369317,NCT00002798
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT03730064,NCT02294591,NCT01797575,NCT05340504
|
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00002611,NCT00025103,NCT00047138,NCT00002610
|
Acute erythroid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.35 |
NCT00369317,NCT00006363,NCT00003190,NCT00002798
|
Acute myelomonocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH78Y4 |
NCT00369317,NCT00002798,NCT00006363,NCT00003190
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
ACHE,SNCA,BLM,APP
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
CDC25B,BLM,SLCO1B1,ALOX15
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
APP,GSTP1,PTPRC,FFAR1
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
AKR1B10,BLM,CDC25B,AKR1B10
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
ACHE,SNCA,LMNA,GSTP1
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
ACHE,ADRA2B,ALOX15,THRB
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
HCAR2,BLM,AKR1B10,ALOX15
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA,ADRA2B,F3,FFAR1
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
GLO1,SNCA,BLM,FFAR1
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT00193505,NCT02702492,NCT03161054,NCT00691210,NCT00809341,NCT00350181,NCT00262210,NCT00324467,NCT01746173,NCT01840566,NCT00088530,NCT00504751,NCT03458260,NCT01097057,NCT02371161,NCT00100477,NCT02703272,NCT00626444,NCT03794167,NCT02987244,NCT00250718,NCT03792815,NCT01178645,NCT00712582,NCT00367497,NCT02408042,NCT01458366,NCT01300793,NCT02356159,NCT01178658,NCT01900509,NCT00481832,NCT02836639,NCT03623087
|
Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30 |
NCT03418038,NCT03016871,NCT04871607,NCT01181271,NCT00667615,NCT02227199,NCT01569204,NCT01251107,NCT00026208,NCT03407144,NCT02686346,NCT03517137,NCT01356680,NCT01165112,NCT00439361,NCT00225173,NCT02408042,NCT00388349,NCT01030900,NCT04638790,NCT00691210,NCT00352027,NCT01476839,NCT01920932,NCT01468740,NCT01900509,NCT01169636,NCT04981899,NCT03755804,NCT02298283,NCT02356159
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
ALOX5,GLO1
NCT02735707 |
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
HCAR2,CES1,THRB
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
CASP3,TOP2B
NCT01014767 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
TOP2B,ALOX5
NCT01057615 |
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
ALOX5,TOP2B
AKR1B10 |
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
HCAR2
NCT00796887,NCT04918719 |
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
TOP2B
NCT04261036,NCT03800667 |
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ADRA2B,ACHE
NCT01063205 |
Oral mucositisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01 |
NCT04756622,NCT03581773,NCT02868151
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
NCT00120822,NCT02699099,NCT02878265
|
Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associatedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.5 |
NCT03007147,NCT02538926,NCT01000285
|
Upper respiratory tract disorderDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0Z |
NCT02730364,NCT02678234,NCT02688361
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
NCT01188876,NCT00003380,NCT00003967
|
Stimulant dependence including amphetamines, methamphetamine or methcathinoneDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C46.2 |
NCT01063205,NCT00332605,NCT04405193
|
Cardiac arrestDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC82 |
NCT03509662,NCT04921189,NCT03450707
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT00284427,NCT00703196,NCT00220532
|
Vitamin C deficiency, unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B56.Z |
NCT05009355,NCT02606773,NCT03224572
|
Mixed hyperlipidaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.2 |
NCT00269204,NCT00289900,NCT00269217
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NCT01005303,NCT01115504,NCT04703361
|
Adrenal cortical carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KH2 |
NCT03723941,NCT00304070,NCT03583710
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
NCT01587261,NCT03680911,NCT03679442
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT00480207,NCT02793648,NCT03730064
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT01891747,NCT01502280,NCT01756989
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT01188876,NCT00003967,NCT00003380
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
NCT03268733,NCT02775734,NCT03164421
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
SLCO1B1,ALOX15
NCT01080352 |
Hearing disorderDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AB50-AB57 |
NCT01271088,NCT01131468,NCT00552786
|
CNS embryonal tumour, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8SH6 |
NCT00006461,NCT00936156,NCT00336024
|
Seminoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH9FM4 |
NCT01887340,NCT02341989,NCT03937843
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT03866174,NCT04630964,NCT02269540
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT00275015,NCT01181271,NCT00276809
|
Graft-versus-host diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B24 |
NCT00004904,NCT04945096,NCT00350181
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT01947062,NCT00042835,NCT00020709
|
Symptoms and signs involving cognition, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.Z |
NCT00611897,NCT03306979,NCT03493178
|
Ewing sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B52 |
NCT00568464,NCT02063022,NCT01864109
|
Rhabdomyosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GA1 |
NCT00025363,NCT00162695,NCT01871766
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
NCT00006040,NCT00005823,NCT00005863
|
Extranodal NK/T-cell lymphoma, nasal typeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.6 |
NCT04917250,NCT02825147,NCT02631239
|
Immune thrombocytopenic purpuraDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64.10 |
NCT01808521,NCT03460808,NCT04368598
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
CDC25B,HCAR2,SLCO1B1
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
ALOX5,HCAR2,FFAR1
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
ALOX5
NCT01850680,NCT02293902,NCT02795299,NCT00965653,NCT03172325,NCT03028467,NCT00950989,NCT02504671,NCT00299104,NCT02467504,NCT02833350,NCT01061736,NCT02093026,NCT01010581,NCT02762838,NCT00298272,NCT01711359,NCT02930343,NCT02393378,NCT01116141,NCT00578305,NCT01873443,NCT01217814,NCT00266227,NCT02379091,NCT00243412,NCT00299130,NCT05363917 |
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04900415,NCT04335084,NCT04482686,NCT04446104,NCT05283954,NCT04354428,NCT04370288,NCT04344184,NCT04928495,NCT04363216,NCT04631536,NCT04347889,NCT04401150,NCT05029037,NCT04328961,NCT04374461,NCT02735707,NCT04357782,NCT04703036,NCT04356690,NCT04395768,NCT04334512,NCT03680274,NCT04792021,NCT04545008
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
GSTP1
NCT00329498,NCT01729845,NCT00369317,NCT00003816,NCT00003243,NCT00803530,NCT02356159,NCT03164057,NCT00002517,NCT00002800,NCT00005863,NCT00006363,NCT00005946,NCT00006040,NCT00002926,NCT00003602,NCT00304018,NCT00005823,NCT00774046,NCT00003436,NCT00004904 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
PTPN1,TOP2B
NCT03175341,NCT03535961,NCT00020722,NCT00004906,NCT00693719,NCT04452370,NCT00012311,NCT00002836,NCT01878695,NCT01589159,NCT00004900,NCT03923179,NCT00006260,NCT00002509,NCT00810017,NCT03121989,NCT00006032,NCT01492556 |
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
NCT00020566,NCT01294670,NCT00334867,NCT00043979,NCT00072280,NCT00077285,NCT00003937,NCT00003052,NCT00002936,NCT00061893,NCT00002516,NCT00006734,NCT00742924,NCT00354744,NCT00003141,NCT00470223,NCT00204646,NCT00014313,NCT00002974,NCT00379457
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
CDC25B,ALOX5
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
PTPN1,ALOX5
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
ACHE
NCT00716066 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
FFAR1,PTPN1
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
MAPK1
NCT01612221 |
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
PTPN1
NCT01083329 |
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
PTPN1
NCT00300365 |
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
THRB,TSHR
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
ALOX5,FFAR1
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
TOP2B
NCT00000660 |
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
CES1,HCAR2
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
TOP2B
NCT03843541 |
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT00807807,NCT00000600
|
FlushingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME64.4 |
NCT00536237,NCT00533611
|
Schizophrenia or other primary psychotic disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A2Z |
NCT00202280,NCT01720095
|
Other specified sphingolipidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C56.0Y |
NCT02583672,NCT00975689
|
Retinal vascular occlusionDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74 |
NCT00500045,NCT00493064
|
Acute basophilic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.37 |
NCT00006363,NCT00369317
|
Cleft palateDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA42 |
NCT00098319,NCT00397917
|
Cerebrovascular diseases, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B2Z |
NCT00000600,NCT00000599
|
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT02730949,NCT02109315
|
FatigueDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG22 |
NCT00633581,NCT02521077
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT00000152,NCT00000161
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
NCT03522922,NCT03090048
|
Intracranial injury, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07.Z |
NCT01322009,NCT04291066
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NCT02107976,NCT02297399
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
NCT00120289,NCT04920448
|
Asymptomatic stenosis of intracranial or extracranial arteryDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD55 |
NCT00000600,NCT00000599
|
Common cold disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SA60 |
NCT05070650,NCT02379637
|
Other specified infectious meningitis not elsewhere classifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.Y |
NCT03101579,NCT05289908
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT05378919,NCT04801511
|
Lymphoid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7Q12 |
NCT03328104,NCT02523976
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT03541486,NCT01852890
|
Beta thalassaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A50.2 |
NCT02083575,NCT04260516
|
Spina bifida, unspecifiedDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA02.Z |
NCT00301587,NCT00452829
|
MyelofibrosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A22 |
NCT01014546,NCT05123365
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT01426438,NCT01435018
|
Preterm newborn, unspecifiedDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA21.4Z |
NCT03596125,NCT00218946
|
Injury of lung, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NB32.3Z |
NCT00655928,NCT04344184
|
Oligodendroglioma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH8844 |
NCT02168270,NCT00303849
|
Astrocytoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH96C7 |
NCT02168270,NCT02372409
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT00996424,NCT00809094
|
Choroid plexus tumoursDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.22 |
NCT00500890,NCT01014767
|
Polycythaemia veraDisease Category: X.Extension CodesDisease ICD-11 Code: XH0453 |
NCT01014546,NCT05123365
|
GanglioneuroblastomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH77W7 |
NCT03786783,NCT02176967
|
Refractory anaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A30 |
NCT00002798,NCT00209833
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT02735707,NCT02186158
|
Cleft lipDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA40 |
NCT00098319,NCT00397917
|
Alcoholic hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94.1 |
NCT00863785,NCT00962442
|
Post-traumatic stress disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B40 |
NCT01664260,NCT03752918
|
Diseases of the blood or blood-forming organs, unspecifiedDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT01220297,NCT03252925
|
Neurofibromatosis type 1Disease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D.10 |
NCT04481035,NCT04481048
|
Nephroblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5QN3 |
NCT00379340,NCT05384821
|
AsphyxiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD11.1 |
NCT04357782,NCT03066115
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
NCT00388856,NCT03451266
|
TrichotillomaniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B25.0 |
NCT00354770,NCT00993265
|
Other specified syndromes with multiple structural anomalies, not of environmental originDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F.1Y |
NCT00446147,NCT04381897
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00300352,NCT01878669
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
NCT00211653,NCT00736866
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
HCAR2
NCT00275418 |
Other specified gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0Y |
NCT02265770,NCT01032070
|
Diseases of the visual system, unspecifiedDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9E1Z |
NCT01015209,NCT01753752
|
Castlemans diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B2Y |
NCT02228512,NCT04585893
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00004904,NCT00003816
|
Female infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA31 |
NCT03862586,NCT05460858
|
Teratoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH83G5 |
NCT00053352,NCT00104676
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
HCAR2,TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
ADRA2B,TSHR
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
ACHE,HCAR2
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
BLM,SLCO1B1
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
ACHE,HCAR2
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
AKR1B10,BLM
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT01057589,NCT00193596,NCT00024310,NCT00653068,NCT00027898,NCT00006047,NCT02157792,NCT00878449,NCT02794571,NCT04047862,NCT00573690,NCT00003194,NCT00811993,NCT03628131,NCT02964013,NCT04469530,NCT00551005,NCT03617432,NCT00009815
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NCT00440869,NCT00506506,NCT00575419,NCT01251029,NCT01356966,NCT02088502,NCT03636932,NCT02791906,NCT05284656,NCT01210456,NCT02947750,NCT01232257,NCT00998972,NCT00830193,NCT01017796,NCT00497328,NCT00780962,NCT01704482,NCT04916080
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
ALOX5,ACHE,ADRA2B
NCT00631111,NCT01201954,NCT00482560,NCT01503060,NCT02990364,NCT03745963,NCT03082001,NCT01561547,NCT00519207,NCT00949104,NCT04732000,NCT02174705,NCT03272594,NCT01190995 |
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
HCAR2,THRB
NCT03510884,NCT00943124,NCT00376584,NCT01984073,NCT00664287,NCT00903617,NCT00961636,NCT02890992,NCT00111891,NCT00630877,NCT00944645,NCT00626392,NCT01071291,NCT00728910,NCT01104519 |
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
PTPRC,TOP2B
NCT02961816,NCT00004086,NCT00242996,NCT00006455,NCT00025636,NCT00040690,NCT00983944,NCT00079105,NCT00003578,NCT00933673,NCT00005964,NCT02701673,NCT00641381,NCT02589145,NCT00274924,NCT00005613,NCT00080886,NCT00020943,NCT00265031,NCT00521014,NCT00003402,NCT00003816,NCT00002494,NCT00908180,NCT00004031,NCT00678327,NCT01390584,NCT00005985,NCT05367856,NCT00002982,NCT00002905,NCT00577629,NCT00117598,NCT00998946,NCT00002715,NCT00003262,NCT00002471,NCT00723658,NCT00032149,NCT00003114,NCT03188198,NCT00109928,NCT00003243,NCT00005090,NCT00003113,NCT00416832,NCT00002691,NCT00003423,NCT00217503,NCT00002565,NCT00255723,NCT00003575,NCT00006373,NCT00002829,NCT00948090,NCT00002557,NCT00058292,NCT00006695,NCT00007852,NCT00041327,NCT00005867,NCT00499343,NCT00018954,NCT00002714,NCT00006708,NCT01046825,NCT05081479,NCT00003397,NCT00801918,NCT00005977,NCT00439556,NCT00004010,NCT00039195,NCT02359162,NCT00598169,NCT00003541,NCT00004907,NCT00052923,NCT00098774,NCT00002510,NCT00002481,NCT01983969,NCT00559104,NCT00003650,NCT00070187,NCT00568607,NCT00398554,NCT00003815,NCT00569985,NCT00041210,NCT00002522,NCT00003957,NCT00003389,NCT00002987,NCT02436707,NCT00264953,NCT00345865,NCT00515138,NCT00002757,NCT00562978,NCT05006664,NCT00002697,NCT00025064,NCT00720447,NCT00016887,NCT00053768,NCT00244946,NCT00005589,NCT00003421,NCT00004169,NCT00118209,NCT00450801,NCT00472056,NCT00049595,NCT00666484,NCT00003728,NCT01329900,NCT00002488,NCT01511562,NCT00039130,NCT00002461,NCT00032019,NCT00920153,NCT00006669,NCT00002835,NCT00003215,NCT00002766,NCT00060385,NCT00392834,NCT00109031,NCT00002936,NCT00732498,NCT00005631,NCT00577993,NCT00822120,NCT00002941,NCT00233987,NCT00002590,NCT00012051,NCT00002521,NCT00265889,NCT00695409,NCT00007865,NCT00028665,NCT00004898,NCT00069238,NCT00002827,NCT00003632,NCT00005998,NCT00003631,NCT00829205,NCT00049439,NCT00005578,NCT00536978,NCT01063439,NCT01516567 |
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TOP2B
NCT00005612,NCT01188876,NCT00284427,NCT00274950,NCT00053352,NCT00003967,NCT03901118,NCT00003380,NCT03298074,NCT05422183,NCT04520074,NCT02562365,NCT04000295,NCT02867956 |
RetinoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D02.2 |
NCT00072384,NCT00004006,NCT01783535,NCT02137928,NCT02870907,NCT00186888,NCT01906814,NCT02116959,NCT04681417,NCT00002675,NCT00110110,NCT00554788,NCT00335738,NCT01899066,NCT00179920
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT01983969,NCT00034463,NCT00441870,NCT00441207,NCT02018861,NCT00957359,NCT00109031,NCT04778410,NCT01050621,NCT02937116,NCT00002854,NCT01604863,NCT00003597,NCT02574728,NCT00881166
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
ACHE,CDC25B,SNCA,CES1,BLM,LMNA,HCAR2,PTPN1,APP,ALOX5,CASP3,GSTP1,AKR1B10,ALOX15,PTPRC
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
GSTP1,TOP2B
NCT00002650,NCT00096330,NCT02066688,NCT01426490,NCT04337879,NCT00973609,NCT00611000,NCT02969681,NCT03769935,NCT04516681,NCT00070434,NCT03100955 |
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT00002876,NCT05124951,NCT00006258,NCT00003996,NCT00278278,NCT00025324,NCT00003859,NCT00278252,NCT00004224,NCT00047281,NCT00003621,NCT00392886,NCT00003309,NCT00084838
|
HypercholesterolaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.0 |
NCT01321034,NCT00203476,NCT00080275,NCT00652431,NCT00378833,NCT01054508,NCT00269217,NCT00271817,NCT00533312,NCT01071525,NCT00082251,NCT00769132,NCT00536510,NCT03510715
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
ACHE,CDC25B,SNCA,BLM,MAPK1,APP,ALOX5,GLO1,SLCO1B1,NCOA3,THRB,PTPRC,TOP2B
NCT00053352 |
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
ACHE,LMNA,BLM,TSHR,PTPN1,GLO1,CASP3,GSTP1,NCOA3,F3,GFER,THRB,TOP2B,FFAR1
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT00812266,NCT00057837,NCT03116971,NCT03850067,NCT03059667,NCT00927875,NCT05403723,NCT00977561,NCT00682981,NCT04363255,NCT02748889,NCT00537511,NCT00926640,NCT00526396,NCT03135977,NCT03041311,NCT03699956,NCT00958022,NCT05092412,NCT00887159,NCT04234607,NCT03711305,NCT00613626,NCT03066778,NCT04878016,NCT04696939,NCT05468489,NCT00363415,NCT04712903,NCT04675697,NCT05116007,NCT00143455,NCT02499770,NCT05309629,NCT04740021,NCT01859741,NCT04490421,NCT05361395,NCT02875457,NCT00066742,NCT04189094,NCT02819999,NCT00912392,NCT04422210,NCT00702962,NCT02934503,NCT04542369,NCT05142696,NCT00401609,NCT01450761,NCT00079040,NCT01563601,NCT01064466,NCT03781869,NCT01987232,NCT05484583,NCT02763579,NCT00042978,NCT00453154,NCT04684017,NCT02402920,NCT04346914,NCT02949895,NCT04683198,NCT00916669,NCT00791154,NCT02179528,NCT05161533,NCT04028050,NCT02289690,NCT04063163,NCT05384015,NCT05091567,NCT05354700,NCT00826644,NCT04730999,NCT03043872,NCT04745689,NCT04005716,NCT00717938,NCT05245994,NCT04924101,NCT02323737,NCT00544596,NCT05353257,NCT04996771,NCT01555710,NCT04665856,NCT04622228,NCT04660097,NCT01573338,NCT04774380,NCT01722292,NCT03613597,NCT00658580,NCT01439568,NCT03700359,NCT04923776,NCT00043927,NCT03389087,NCT00168896,NCT05026593,NCT02722369,NCT04702880,NCT00388960,NCT02738346,NCT03467360,NCT04696575,NCT03382561,NCT02815592,NCT02580994,NCT05224141,NCT00320359,NCT00017251,NCT04560972,NCT02899728,NCT05001412,NCT04256421,NCT01237678,NCT04472949,NCT04012606,NCT04624204,NCT04543890,NCT02337712,NCT02194049,NCT04728230,NCT04699838,NCT04254471,NCT04101357,NCT04951115
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT00216099,NCT00003084,NCT00514540,NCT02861573,NCT00973882,NCT00004054,NCT00028769,NCT05501548,NCT00483561,NCT00627354,NCT00151060,NCT00176605
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
PTPN1,FFAR1
NCT00485758,NCT01368328,NCT02786823,NCT03437902,NCT01319734,NCT03540758,NCT00618995,NCT00609102,NCT03685773 |
Precursor B-lymphoblastic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A70 |
NCT02881086,NCT02845882,NCT00195871,NCT01451515,NCT03023046,NCT03328104,NCT00058461,NCT03564704,NCT00073918,NCT03991884,NCT02043587
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CDC25B,SNCA,LMNA,HCAR2,ALOX5,CASP3,GSTP1,AKR1B10,ALOX15,PTPRC,FFAR1
|
Mantle cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.5 |
NCT03019640,NCT01181271,NCT00114738,NCT02896582,NCT00005780,NCT00571493,NCT00209222,NCT00086944,NCT00878254,NCT00073918
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
NCT00104676,NCT03937843,NCT00003941,NCT00231582,NCT00053352,NCT00324298,NCT00002566,NCT02341989,NCT00002596,NCT00936936
|
Medulloblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8P29 |
NCT00031590,NCT00749723,NCT00180791,NCT00336024,NCT02502708,NCT04501718,NCT01857453,NCT01356290,NCT02025881,NCT00006461
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
HCAR2,TSHR,ALOX5,GLO1,CASP3,GSTP1,AKR1B10,ALOX15,THRB,PTPRC
|
Dentofacial parafunctional disordersDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0E.7 |
NCT02870543
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
TOP2B
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
ACHE
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
ACHE
|
ChemoprotectionDisease Category: NADisease ICD-11 Code: N.A. |
TOP2B
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
TOP2B
|
Parasitic worm infestationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F90 |
ACHE
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
ALOX5
|
PediculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G00 |
ACHE
|
Bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20-GA21 |
F3
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
TOP2B
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
PTPRC
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
TOP2B
|
Synthesis disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52-5C59 |
CES1
|
Autonomic nervous system disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D87 |
SNCA
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
ACHE
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MAPK1
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
TOP2B
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
PTPRC
|
Diagnostic imagingDisease Category: NADisease ICD-11 Code: N.A. |
APP
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
ALOX5
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
APP
|
Dystrophic epidermolysis bullosaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EC32 |
APP
|
Ophthalmic devices/implants/grafts injuryDisease Category: 23.External causes of morbidity or mortalityDisease ICD-11 Code: PK97 |
PTPN1
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
|
Carcinoid syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B10 |
ALOX5
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
ALOX5
|
SyphilisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A61-1A6Z |
TOP2B
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
|
Peroxisomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C57 |
CES1
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
ADRA2B
|
Unspecific substance harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE6Z |
ACHE
|
DyslipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80-5C81 |
HCAR2
|
FilariasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F66 |
ALOX5
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TOP2B
|
AmyloidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5D00 |
APP
|
Desmoid tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7C |
APP
|
Common wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E80 |
TOP2B
|
Oesophageal/gastroduodenal disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD90 |
ACHE
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
PTPRC
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
TOP2B
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
HCAR2
|
Gonococcal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A70-1A7Z |
TOP2B
|
Diabetic polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C03.0 |
NCT00634998
|
Recurrent pregnancy lossDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA33 |
NCT01976676
|
Aortic valve stenosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB70 |
NCT02109614
|
Cutaneous T-cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1951 |
NCT00554827
|
Sezary syndromeDisease Category: X.Extension CodesDisease ICD-11 Code: XH8HN3 |
NCT01134341
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
NCT01183065
|
Other specified effects of air pressure or water pressureDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NF04.Y |
NCT01187108
|
Uterine fibroidDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E66 |
NCT01715597
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT01118624
|
Postpartum haemorrhageDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA43 |
NCT02424201
|
Unspecified undernutritionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B7Z |
NCT00396500
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT04783792
|
Huntington diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01.10 |
NCT04478734
|
Pulmonary alveolar proteinosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB04.31 |
NCT03887169
|
MenopauseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA30.0 |
NCT00000555
|
Idiopathic rhabdomyolysisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB32.20 |
NCT00391911
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT01550510
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT01953536
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT01384591
|
Mycosis fungoidesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B01 |
NCT01134341
|
Anterior uveitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A96 |
NCT01900431
|
Vitamin A deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B55 |
NCT00128557
|
Tuberculosis of the respiratory systemDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10 |
NCT03882177
|
ShockDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG40 |
NCT01587963
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NCT00154700
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NCT00004467
|
Temporomandibular joint disordersDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0E.8 |
NCT02602483
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT01436266
|
Infantile spasmsDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62.0 |
NCT01828437
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
NCT04898023
|
Parasitic infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D0Y-1G2Z |
NCT00396500
|
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT00855257
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT04035096
|
Burn and burn infectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND90-NE2Z |
NCT00734695
|
Basal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C32 |
NCT04279535
|
Adult T-cell leukaemia/lymphoma (HTLV-1 positive)Disease Category: X.Extension CodesDisease ICD-11 Code: XH6TE2 |
NCT00145002
|
Atherosclerotic chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD40.Z |
NCT00804843
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
NCT04123405
|
Other specified primary disorders of musclesDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C7Y |
NCT02505087
|
Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional languageDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02.0 |
NCT00453180
|
Noninfectious erosive or ulcerative disorders of oral mucosaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.1 |
NCT04989049
|
Infectious gastroenteritis or colitis without specification of infectious agentDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A40.Z |
NCT00133406
|
Congestive heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10 |
NCT00787059
|
Pilocytic astrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH12D2 |
NCT02372409
|
Disorders of muscles, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB3Z |
NCT03223519
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT04046094
|
Movement disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A07-8A0Z |
NCT01908452
|
Refractory anaemia with excess of blastsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A35 |
NCT00002798
|
Pleural mesotheliomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26 |
NCT01569919
|
Complex regional pain syndromeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.04 |
NCT02390505
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
NCT00763633
|
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.1 |
NCT00073918
|
Embryonal carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8MB9 |
NCT00053352
|
OligoastrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH6F49 |
NCT02372409
|
Diseases of neuromuscular junction or muscle, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D0Z |
NCT02362425
|
Clear cell renal cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH46F1 |
NCT03334409
|
Thrombotic thrombocytopenic purpuraDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64.14 |
NCT01808521
|
Harmful effects of drugs, medicaments or biological substances, not elsewhere classifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE60 |
NCT02908581
|
Other specified inborn errors of energy metabolismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C53.Y |
NCT05241262
|
Small cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0YB0 |
NCT05058651
|
Hepatic veno-occlusive diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB98.6 |
NCT04712435
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
NCT02541045
|
BacteraemiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MA15.0 |
NCT02040818
|
Disorders of peroxisomal alpha-, beta- or omega-oxidationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C57.1 |
NCT01495260
|
Respiratory failureDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB41 |
NCT01985685
|
Cardiac arrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC9Z |
NCT04154982
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
NCT00002798
|
Malignant neoplasm metastasis in male genital organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E06 |
NCT02516670
|
Hereditary sensory or autonomic neuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C21.Z |
NCT00271635
|
AnorexiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG43.7 |
NCT01295450
|
Inappropriate saccadesDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C85.02 |
NCT00716066
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
NCT00000161
|
Chronic kidney disease, stage unspecifiedDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61.Z |
NCT00136188
|
Noise effects on inner earDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AB37 |
NCT02259595
|
Myeloid sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.39 |
NCT01371981
|
Retinopathy of prematurityDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71.3 |
NCT01238471
|
Malignant neoplasm metastasis in mediastinumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D71 |
NCT00003941
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
NCT03980925
|
Malignant neoplasms of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A |
NCT01525927
|
Relapsing-remitting multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.0 |
NCT00288626
|
Waldenstrom macroglobulinemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH8GW4 |
NCT00073918
|
T lymphoblastic leukaemia/lymphomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH50W7 |
NCT02538926
|
Oligodendroglioma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7W59 |
NCT02372409
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04482686
|
Chronic myeloid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4XG8 |
NCT00780104
|
Drug-induced or toxic liver disease with chronic hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB95.1 |
NCT02182167
|
Acute promyelocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1A50 |
NCT03624270
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
NCT01082445
|
Biliary atresiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB95.1 |
NCT03499249
|
Acute ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.0 |
NCT04023266
|
Disorders of methionine cycle or sulphur amino acid metabolismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50.B |
NCT00483314
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NCT03956888
|
Optic nerve disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C40 |
NCT02372409
|
Endothelial corneal dystrophyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A70.0 |
NCT04440280
|
Neuromyelitis opticaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A43 |
NCT00716066
|
Chronic inflammatory demyelinating polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C01.3 |
NCT00716066
|
Alcohol beverageDisease Category: X.Extension CodesDisease ICD-11 Code: XM1A61 |
NCT03238300
|
Diabetic lactic acidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A22.1 |
NCT00143702
|
Duplications of the short arm of chromosome 17Disease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD41.G1 |
NCT00484510
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
NCT02504359
|
Ependymoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH6922 |
NCT01096368
|
Mild hyperemesis gravidarumDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA60.0 |
NCT00861523
|
Other specified malignant neoplasms of the ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.Y |
NCT02429700
|
Acute myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41 |
NCT01741207
|
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT01013779
|
Transposition of the great arteriesDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA85.1 |
NCT00374088
|
Macro reentrant atrial tachycardia, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.2Z |
NCT00953212
|
NeutropeniaDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B00 |
NCT00002800
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NCT00133419
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT02199184
|
Mental/behavioural/neurodevelopmental disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6E20-6E8Z |
NCT01354132
|
Drug-induced or toxic liver disease, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB95.Z |
NCT01118663
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT00003346
|
ThymomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NCT00387868
|
Malignant trophoblastic neoplasms of placentaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C75.0 |
NCT02639650
|
Hypertrophic cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.1 |
NCT01537926
|
Neuropathic painDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43.0 |
NCT01840345
|
Acute pyelonephritisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB51 |
NCT02080182
|
Orthostatic hypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA21 |
NCT04855266
|
Mature B-cell neoplasms, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A8Z |
NCT02911142
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT02595424
|
Alveolar rhabdomyosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7099 |
NCT01055314
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
NCT04557215
|
Tumours of neuroepithelial tissue of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.2 |
NCT02653196
|
Embryonal rhabdomyosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH83G1 |
NCT01055314
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT00351195
|
Bulimia nervosaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B81 |
NCT01033149
|
Myeloproliferative and myelodysplastic disease, unclassifiableDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A44 |
NCT00003243
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT03669783
|
Chronic bronchitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA20.1 |
NCT00205647
|
Tourette syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A05.00 |
NCT01172288
|
Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cordDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E4A.0 |
NCT00716066
|
Diseases of the nervous systemDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 08 |
NCT04987775
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT02502708
|
Pseudomyxoma peritoneiDisease Category: X.Extension CodesDisease ICD-11 Code: XH83J5 |
NCT04982146
|
Ischaemia reperfusion injury of liverDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB98.B |
NCT01771978
|
Chronic widespread painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.01 |
NCT04594733
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
HCAR2
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
ACHE
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
SLCO1B1
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
F3
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
AKR1B10
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
BLM
|
Malaria, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F4Z |
HCAR2
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FFAR1
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
HCAR2
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
ADRA2B
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
HCAR2
|
❱❱❱ Network Visualization of Plant-Targeted Human Disease Associations
Plant-Targeted Human Disease Network
>> Targets derived from weak experimental activities
